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Abstract 
Objective. – The main focus is on patients who are admitted into hospitals 
because of  asthma. The data source is National Inpatient Sample (NIS). The 
trend of  admissions over the years 2006 to 2012 is examined. More than 
450,000 are admitted into the hospitals because of  asthma averaged over the 
years 2006 to 12. One can contrast this number with the prevalence of  asthma. 
More than 22 millions have asthma averaged over the years 2006 to 12. We 
will refine such contrasts with respect to gender, age (adult versus child), states 
and race. In addition, focusing exclusively on NIS, we examine, length of  stay, 
insurance coverage, and hospital charge, among others. There are 14 different 
types of  asthma as detailed by ICD-9 codes. We identify the top five asthma 
types with respect to frequency of  admissions. We contrast each asthma type 
with respect to gender and race. We examine variation in the average of  length 
of  stay among the top five asthmatic types. 
Design. – We pursue a short-term trend analysis of  hospital admissions due 
to asthma focusing on the years 2006 to 2012. 
Source. - National Inpatient Sample (NIS) from the Health Cost and 
Utilization Project (HCUP) and National Health Interview Survey (NHIS) 
from the Center for Disease Control and Prevention (CDC). 
Results. – 1. Of  those who are asthmatics, 43.2% are males and 56.8% 
females, averaged over the years 2006 to 12. In contrast, among those who 
are admitted into hospitals, 37.6% are males and 63.4% females, averaged over 
7 years. Among children (< 18 years) and among those who are asthmatics, 
57.2% are males and 42.8% females. In contrast, 62.8% are males and 37.2 
females among those who are admitted into hospitals because of  asthma. The 
2 
 
picture is different among adults ( ≥  18 years). Among those who are 
asthmatic, 34.3% are males and 65.7% females. In contrast, 28% are males 
and 72% females among those who are admitted into hospital because of  
asthma. 
2. The average percentage of  admissions into hospitals because of  asthma is 
1.68 with standard error 0.03, the baseline being all admissions into hospitals. 
The difference between males (1.52 ±  0.03) and females (1.75 ±  0.03) is 
significant. The difference between adults (1.59 ±  0.03) and children (1.95 ±  
0.07) is also significant.  
Conclusion. – Differences in the rates of  admissions between males and 
females, between adults and children, and also between boys and girls are 
significant. Differences in length of  stay are also significant by gender wise. 
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Introduction 
Asthma is a major health issue. According to the 2013 numbers released 
by the Centers for Disease Control and Prevention (CDC), more than 22.6 
million (about 7%) in the United States have asthma [1]. Unfortunately, 
there is no radical cure currently available for asthma. Even when the 
patient is asymptomatic, the disease is merely dormant and can flare up at 
any time. However, with current knowledge and treatments, most people 
who suffer from asthma are able to control the disease. They can still enjoy 
normal lives, engaging in exercise and sleeping soundly at night without 
the disruption of  asthma. In order to find out how asthma plays out 
demographically and economically, we need extensive data on this disease. 
We focus on the NIS as our data source. The following aspects are covered 
in this paper.  
1. Estimate the total number of  admissions due to asthma over the period 
2006 to 2012. Not every state provided admissions data. Using the data 
provided by the participating states, we estimate that total number of  
admissions in the entire nation and calculate its standard error for each 
year of  interest. 
2. Determine the gender distribution of  admissions due to asthma. 
Nationwide 7.0% are males and 9.2% are females averaged over 2006 – 
2012 [2]. Assuming equal number of  males and females, among asthma 
sufferers, 43.2% are males and 56.8% females. The question we want to 
address is whether this gender distribution is reflective in hospital 
admissions too. 
3. Determine the age distribution of  hospital admissions due to asthma 
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gender-wise. It is reported that boys (0 – 7 years) are twice likely to have 
asthma as girls [3, 4]. 
4. Asthma is a broad name. There are 14 different major types of  asthma are 
noted in the form of  ICD-9 codes [5]. Since there are significant 
differences in admission rates gender-wise, determine top five asthma 
diagnoses gender-wise. 
5. The length of  stay in a hospital is another feature that is examined gender-
wise. Another issue that is being investigated is how the length of  stay 
varies with respect to the top five diagnoses of  asthma gender-wise. 
6. Seeking admission into a hospital because of  asthma cannot be expected 
to be elective. Moving from emergency into a hospital is natural. Examine 
statistics of  these movements. 
7. The minorities are reported to have higher prevalence of  asthma. We 
examine whether such a phenomenon persists in hospital admission too. 
8. Hospital charges per day are also examined for each of  the top 5 asthma 
diagnoses. 
9. A patient is admitted for any number of  1000 medical diagnoses as 
exemplified by the DRG code. Determine the distribution of  admission 
by race. Determine the distribution of  admissions by race and asthma. The 
ratio of  these distribution by race will provide a measure of  gender 
disparities. 
10. Who pays the hospital charges? The patient might have private insurances 
or covered by Medicare or Medicaid. He might be paying from his own 
pocket. A contingency table of  who pays versus race will provide a good 
understanding of  payment coverage and race. We examine contingency 
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tables year by year. 
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Data 
To examine prevalence of  asthma, National Health Interview Survey 
(NHIS) conducted on yearly basis is a good source. The entire country is 
stratified into approximately 1900 primary sampling units (PSUs). Each PSU 
is either a county, a collection of  contiguous counties, or a metropolitan area 
[6]. A random sample of  428 PSUs is selected. From each PSU a sample of  
households is selected. From each household, an adult and a child are selected 
at random for the survey. The total number of  households in the sample is 
approximately 35,000 and the number of  individual is 87,000 [7]. We will use 
summary reports and national estimates coming from these surveys. For 
hospital admissions, the data comes from HCUP under the label NIS. The 
data is collected on an yearly basis from 1988 to 2012. HCUP is funded by 
the Agency for Healthcare Research and Quality (AHRQ). Federal and state 
governments, along with industry, compiled and maintained by the HCUP [8].  
NIS is the largest all-payer inpatient care database in the United States, 
containing data on more than seven million hospital stays [8]. Its large sample 
size is ideal for developing national and regional estimates and enable analysis 
of  rare condition, uncommon treatments, and special populations.  
From each year’s NIS data, the sampling frame is the collection of  all 
hospitals in the USA and discharges. Each admission into a hospital is labeled 
as ‘discharge’. VA hospitals, hospitals located in the Indian reservations, and 
long-term care hospitals are excluded from the sampling frame. Not every 
state is in the samplings frame. Roughly 20% of  the hospitals from the 
participating states are selected [9]. Table 1 shows the number of  participating 
states, hospitals, and discharges in the sample for the 25-year data. At the 
12 
 
beginning of  this data, there were only 759 hospitals in 8 states included. As 
time passed, more and more states and hospitals participated in the NIS study. 
In 2006, there were 1044 hospitals in 38 states have been enrolled in the 
system, roughly 8 million discharges each year have taken place since 2006 
[10]. 
 
Sampling Method 
The data in NIS consists of  a 20% random sample of  discharges from 
the hospitals in the participating states [9]. It was determined that 
approximately 40 million discharges occurred in the participating states 
combined. The sampling plan adopted by the HCUP for the years 1988 – 
2011 was a combination of  stratified, cluster, and systematic sampling 
methods. We outline the sampling plan for the year 2006. A total of  3,958 
hospitals, across the participating states, took part in the study. As a first step, 
the hospitals are stratified according to four variables: 1. Geographic region 
(Northeast, Midwest, West, South). 2. Control (Government or private; 
Government, nonfederal; Private, not-for-profit; Private, investor-owned; 
Private, either not-for-profit or investor-owned). 3. Location/Teaching (Rural, 
Urban nonteaching, Urban teaching). 4. Number of  beds (Small, Medium, 
Large). Thus all hospitals located in the Rural, South, which are private not-
for-profit, medium sized of  bed form one stratum. Total number of  strata 
should have been 4 × 5 ×  3 ×  3 = 180. Some strata were small and 
consequently merged. After mergers, only 60 strata were formed. As a second 
step, systematic sampling was used in each stratum. 20% of  the hospitals in a 
stratum are selected by the systematic sampling method. As a third step, 
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cluster sampling was used from the selected hospital. All hospital discharges 
in the selected hospitals are included in the sample. From 3,958 hospitals, 
1045 hospitals were selected and all their discharges ended up in the sample 
in the year 2006. 
NIS changed the sampling strategy for the year 2012. From each hospital 
in the participating states, a 20% random sample of  discharges was selected. 
A total of  4,378 hospitals from 44 states participated in the NIS study [11]. 
From each of  these hospitals, a 20 % random sample of  discharges was 
selected. The HCUP made a statement that this is a better sampling plan 
because of  reduction in standard errors. 
 
Structure of  the Data 
Information from the data falls into four groups. 1. Core information: 
main data on discharges comes from several variables. Some of  which are: (A) 
Age (the age of  the patient when admitted). (B) Date of  admission. (C) Date 
of  discharge. (D) LOS (length of  stay). (E) Reason for admission (coded-
APSDRG). (F) Co-morbidities (coded-APSDRG). (G) Insurance details. (H) 
TOTCHG (cost of  stay). (I) Zip code of  the hospital. (J) DRG code (The 
medical condition the patient was admitted was codified from 001 to 999). 2. 
Hospitals: hospital-level information. Data elements include, but are not 
limited to the following variables: (A) Discharge weight (DISCWT). (B) 
Hospital identifiers (HOSPID). (C) Hospital state (HOSPST). (D) Hospital 
weight (HOSPWT). 3. Severity: discharge-level information provides four 
different sets of  disease severity measures. The unit of  observation is an 
inpatient stay record. 4. Groups: discharge-level information facilitates the use 
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of  the ICD-9-CM diagnostic and procedure information in the HCUP 
databases. The unit of  observation is inpatient stay record.  
 
Disease coding system – Diagnosis-related group (DRG) 
A diagnosis-related group (DRG) is a system to classify hospital cases 
into one of  approximately 500 groups, also referred to as DRGs, expected to 
have similar hospital resource use and developed for Medicare as part of  the 
prospective payment system. DRGs are assigned by a “grouper” program 
based on ICD diagnoses, procedures, age, sex, discharge status, and the 
presence of  complications or comorbidities [12]. DRGs have been used in 
the United States since 1983 to determine how much Medicare pays the 
hospital, since patients within each category are similar clinically and are 
expected to use the same level of  hospital resources. DRGs may be further 
grouped into major diagnostic categories (MDCs). The original objective of  
purpose for DRGs was to develop a patient classification system that related 
types of  patients treated to the resources they consumed. Since the 
introduction of  DRGs in the early 1980s, the healthcare industry has evolved 
and developed an increased demand for a patient classification system that 
can serve its original objective at a higher level of  sophistication and precision. 
To meet these evolving needs, the DRG system had to expand in scope. 
The hospitals use DRG codes from 000 to 999 to classify the reason the 
patient was admitted into the hospital. These codes are very broad. As a 
contrast, ICD-9 code has approximately 17,000 numbers to classify medical 
conditions, whereas ICD-10 has approximately 170,000 numbers to classify 
medical conditions. One column in the data gives the DRG code and another 
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column (DX1-column) gives the ICD-9 code for the specific reason the 
patient was admitted into the hospital. DRG codification is not the same for 
all years. A document is available outlining which DRG codification should 
be used for the year of  interest. One column in the data gives DRG code for 
the specific reason the patient was admitted into the hospital. From years 
2008–2012, DRG 202 represents Bronchitis and asthma with major 
complications. DRG 203 represents Bronchitis and asthma without major 
complications. DRG technology has evolved to include changes in healthcare 
delivery and advances in medicine. It is going to be updated to version 32 by 
October 1, 2015. For the years 2008–12, the same DRG code was used for 
asthma. Before 2008, DRG 96 equals Bronchitis and asthma with major 
complications of  patients aged over 17, DRG 97 presents Bronchitis and 
asthma without major complications of  patients aged over 17, and DRG 98 
represents Bronchitis and asthma of  patients with age ranging 0 to 17. The 
numbers DRG 202 and 203 were first used in October 2007. There are 
consistent in meaning for the years 2008 to 2012. 
 
International Classification of  Disease 
The International Statistical Classification of  Diseases and Related 
Health Problems, shortly named as International Classification of  Disease 
(ICD), is the international “standard diagnostic tool for epidemiology, health 
management and clinical purpose” [13]. It is maintained by the World Health 
Organization (WHO). The ICD is a health care classification coding system, 
offering diagnostic codes for classifying diseases, including nuanced 
classifications of  a wide variety of  signs, symptoms, abnormal findings, 
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complaints, social circumstances, and external causes of  injury or disease. 
ICD is revised periodically. ICD is presently in its 10th revision. ICD-9 code 
has approximately 17,000 numbers to classify medical conditions. ICD-10 has 
approximately 170,000 numbers to classify medical conditions [14]. One 
column (DX1-column) gives the ICD-9 code for the specific reason the 
patient was admitted into the hospital. 
  
17 
 
Methods 
To estimate the total number of  asthma discharges for the states that 
participated in the study in each year, we used the “domain analysis” method 
for the total. It is not clear at the outset how to estimate the total number of  
discharges for the missing states. We followed the following technique: 1) 
Estimate the total number of  discharges along with standard error for each 
participating state using the “domain analysis” method. We surmised that the 
population size of  the state is a good predictor of  the total number of  
discharges for the state. Population sizes are available from the Census Bureau 
for any year of  interest. 2) We obtained a simple linear regression model 
regressing the total number of  discharges on the population size using the 
data from the participating states. The fit was excellent with R2 more than 
90%. 3) We used the regression model as a prediction equation to estimate 
the total number of  discharges for the missing states using their population 
sizes. Standard errors were estimated, in a similar vein, using regression.  
Domain analysis is also known as subgroup analysis, subpopulation 
analysis, or subdomain analysis [15]. The method is to compute the statistics 
for the entire study population by computing the statistics for subpopulations, 
or domains. Formation of  subpopulations can be related to the sample design 
and so the domain sample sizes can actually be random variables. When 
providing national estimates, one needs to take into account their size to 
calculate the weighted sum estimate. NIS provides discharge weight in the 
sample which weighs the sample of  discharges to the total participating states 
population of  discharges. We use the domain statement in SAS (code in the 
appendix) to request a domain analysis. The procedure computes the 
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requested statistics for each domain. For a domain D, let ID be the 
corresponding indicator variable: 
𝐼𝐷(ℎ, 𝑖, 𝑗) = {
 1, 𝑖𝑓 𝑜𝑏𝑠𝑒𝑟𝑣𝑎𝑡𝑖𝑜𝑛 (ℎ, 𝑖, 𝑗) 𝑏𝑒𝑙𝑜𝑛𝑔𝑠 𝑡𝑜 𝐷
0, 𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒
 
Let  
𝑣ℎ𝑖𝑗 = 𝑤ℎ𝑖𝑗  𝐼𝐷(ℎ, 𝑖, 𝑗)
= {
 𝑤ℎ𝑖𝑗 , 𝑖𝑓 𝑜𝑏𝑠𝑒𝑟𝑣𝑎𝑡𝑖𝑜𝑛 (ℎ, 𝑖, 𝑗) 𝑏𝑒𝑙𝑜𝑛𝑔𝑠 𝑡𝑜 𝐷
0, 𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒
 
The requested statistics for variable y in domain D are computed by using the 
new weights v. 
Where: 
h = 1, 2,…, h is the stratum index. 
i = 1, 2, …, nh is the cluster (hospital) index within stratum h. 
j = 1, 2,…, mhi is the unit index within cluster i of  stratum h. 
𝑛 =  ∑ ∑ 𝑚ℎ𝑖
𝑛ℎ
𝑖=1
𝐻
ℎ=1  is the total number of  observations in the sample. 
𝑤ℎ𝑖𝑗 denotes the sampling weight for unit j in cluster i of  stratum h. 
The total discharges/LOS/TOTCHG for all the participating states can be 
calculated by the following equation:  
?̂?𝐷 =  ∑ ∑ ∑ 𝑣ℎ𝑖𝑗 × 𝑦ℎ𝑖𝑗
𝑚ℎ𝑖
𝑗=1
𝑛ℎ
𝑖=1
𝐻
ℎ=1
 
Where:  
𝑌ℎ𝑖𝑗 =  (𝑦ℎ𝑖𝑗
1 , 𝑦ℎ𝑖𝑗
2 , … , 𝑦ℎ𝑖𝑗
𝑃   )   are the observed values of  the analysis 
variables for unit j in cluster i of  stratum h, including both the values of  
numerical variables and the values of  indicator variables for levels of  
categorical variables. 
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The estimated mean of  total discharges/LOS/TOTCHG for all the 
participating states is 
?̂?𝐷 =   
(∑ ∑ ∑ 𝑣ℎ𝑖𝑗 × 𝑦ℎ𝑖𝑗
𝑚ℎ𝑖
𝑗=1
𝑛ℎ
𝑖=1
𝐻
ℎ=1 )
𝑣…
 
Where: 
𝑣… =  ∑ ∑ ∑ 𝑣ℎ𝑖𝑗
𝑚ℎ𝑖
𝑗=1
𝑛ℎ
𝑖=1
𝐻
ℎ=1
 
 
Simple linear regression 
The goal is to ascertain trend over the period 2006-12 in the total number 
of  asthma discharges/LOS/TOTCHG for the entire nation. For the 
participating states, the total discharges/LOS/TOTCHG can be calculated by 
the former equation. To estimate the total discharges/LOS/TOTCHG for 
each of  the non-participating states, we need to do a regression model. We 
debated for possible predictors of  total number of  discharges. Total 
population seems to be a credible and smart choice. The correlation between 
total number of  discharges and total population after logarithms is 0.91. We 
built a weighted simple linear regression model with total number of  charges 
as response and total population after logarithms (R2 = 0.92) with weights 
reciprocals of  squares of  standard errors.  
Suppose there are n data points {(𝑥𝑖 , 𝑦𝑖), i = 1, …, n}. The model that 
describes x and y is:  
𝑦𝑖 = 𝛼 + 𝛽 × 𝑥𝑖 + 𝜀𝑖 
in which 
yi is the ith state estimate (1 ≤ i ≤ 46), 
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α is the intercept, 
β is the regression coefficient, 
xi is the ith state population,  
εi is the ith residual, and 
εi has mean 𝜎 and standard deviation 𝜎2 = standard error of  𝑦𝑖 . 
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Results 
Prevalence 
We start our analysis with prevalence of  asthma, gender-wise, age-wise 
(children versus adults), and state-wise. The source of  data for a discourse in 
this connection is CDC. CDC collects data annually under the theme – 
National Health Interview Survey (NHIS). Pooling the data collected over the 
years 2006 -12. The following estimates averaged over the years of  interest 
are obtained. 
The following graph (Figure 1) gives prevalence of  asthma in percent 
state by state averaged over the years 2006 to 2012. The percentages along 
with standard errors are given in Table A in the appendix year by year and 
state by state including the averages with respect to the years. Figure 2 and 3 
give prevalence of  asthma among males and females, respectively, averaged 
over the years 2006 to 12. The actual numbers are given in Table B of  the 
appendix. Figure 4 and 5 give prevalence of  asthma among children (under 
18) and adults (18 and over). The actual numbers are given in Table C of  the 
appendix. 
Finally, prevalence of  asthma is depicted state by state for male children 
and female children in figure 6 and 7, respectively. 
 
Discussion 
More females than males have asthma (9.8% versus 7.1%). In terms of  
sheer numbers, females outnumber males by more than 4,000,000 per year on 
average. When it comes to children, boys outnumber girls (9.6% versus 7.4%). 
When comparing adults and children, the numbers exhibit parity (8.45% 
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versus 8.46%). 
Hospital discharges 
Not everyone who has asthma goes to hospital for relief. The goal in this 
section is to determine what percentage of  asthmatics end up in hospitals for 
treatment. The data we utilize comes from HCUP in the form of  NIS 
(National Inpatient Sample). The followings table (Table 2) is a summary of  
our findings. 
 
Discharges – All USA 
In the years of  interest from 2006 – 2012 not all states participated. The 
following is the number of  states that participated in the HCUP data of  NIS. 
Using the data one can estimate the total number of  discharges among 
the participating states. One can use hospital discharge weights. As a matter 
of  fact, HCUP has the precise figure for the total number of  discharges, based 
on which it calculated the discharge weights. The goal now is to estimate total 
number of  discharges for the entire USA of  50 states. Using domain analysis 
we estimated the total number of  discharges for each participating state along 
with its standard error. We used states’ population as a predictor to develop a 
simple linear regression model regressing log total number of  discharges 
versus log total population. We used weighted least squares method with 
weights proportioned to reciprocals of  squares of  standard errors. For each 
year under interest, R2 value was over 90%. Population total is a very good 
predictor of  total number of  discharges. Using the model, we predicted total 
number of  discharges for each missing state using its population total. The 
following figure 8 is the graph of  our foray into regression for the year 2008. 
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The following figure 9 is a bar chart of  total number of  discharges along with 
their standard errors. The precise numbers are given in Table D in the 
supplement. 
 
Discharge – Gender Distribution 
We determined that the incidence of  asthma among female is higher than 
that males. The distribution is 63.4% to 37.6% for female versus males over 
years 2006 to 2012. The following figure 10 is the plot of  this result. The 
precise numbers are shown in the Table E in the appendix. 
 
Discharge – Gender by Age Distribution 
About 40% of  males afflicted with asthma are in the decennial age 0 -9, 
whereas for females the percentage is 13.5%. Also, about 60% of  the females 
admitted to hospitals with asthma in the age range of  40 – 79, whereas the 
percentage is about 30% for males. The following figure 11 is a pyramid plot 
of  asthma distribution by gender decennially over years. The actual number 
are given in the Table F in the appendix. 
We also applied different age groups, separated all discharges into adult 
(over 18) and children (less 18). About 62.8% of  male children suffered from 
asthma whereas for females the percentage is 37.2%. With adult, females has 
much higher discharge rate than males. About 28% of  male adult afflicted 
with asthma whereas for females the percentage is 72%. Also, the asthmatic 
patient are more likely in the adult group than children. For males, the 
distribution is 51.9% versus 48.1% and 82.4% versus 17.6% for females. The 
figure 12 is a pyramid plot of  age distribution between adult and children. 
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The actual number are shown in the Table G in the appendix. 
 
 
Average Length of  Stay by Gender wise 
The average of  length of  stay with female patients has longer than the 
male patients. Male patients are about 2.76 days versus the females with 3.57 
days. Female afflicted with asthma are roughly 13% more than males. The 
figure 13 is a bar plot of  this result and the precise numbers are given in the 
Table H in the appendix. We want to test if  there is a significant difference of  
average length of  stay between male and female. As the result shown in the 
table 4, the difference between males (2.76 ±  0.036) and females (3.57 ±  0.043) 
is significant. 
 
Average Charges for Asthma Discharges 
Total charges of  asthma each year from year 2006 to 2012 for the entire 
nation were also estimated based on the method former described. Female`s 
average of  asthma charges are more than male`s, 15,009 dollars per year 
versus 18,471 dollars per year. Also, the average of  asthma discharges exhibits 
a significant increasing trend, from 12,857 dollars in 2006 to 20,892 dollars 
per case in 2012. There is a 60% increasing over years 2006 to 2012. Figure 
14 is a bar plot of  average costs of  asthma discharge. The actual numbers are 
shown in the Table I in the appendix. 
 
The Top 5 Prevalent Asthma Subtypes 
Asthma is a very diverse condition, including 14 subcategories, as 
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identified by ICD-9 code. The prevalence for the different subcategories 
varies quite a bit. Their severity ranges from mild to very severe. Considering 
the nature of  the disease and to be more specific, we further identified the 
top 5 prevalent subcategories from the dataset and focused on the estimation 
of  discharges, length of  stay, and total charges. 
The most prevalent asthma diagnoses are determined for each year. The 
top is unspecified type of  asthma with acute exacerbation (ICD-9 code 
493.92), which accounts for approximately 43% of  all asthma cases. The 
second is chronic obstructive asthma with acute exacerbation (ICD-9 code 
493.22) with 29% prevalence rate. The third is unspecified type with status 
asthmaticus (ICD-9 code 493.91), comprising approximately 10% of  all 
asthma cases. The fourth and fifth are asthma with unspecified type with 
unspecified status (ICD-9 code 493.90) and extrinsic asthma with acute 
exacerbation (ICD-9 code 493.02), which comprise 6% and 4%, respectively, 
of  total discharges of  asthma. A brief  description of  those 5 codes is in the 
table 5.  
We applied the top 5 asthma diagnoses by gender distribution. Except 
493.91, female has higher discharges rate than males with other 4 symptoms, 
especially 493.22, which win by 40.4%. 493.92 and 493.22 play a majority role 
in asthma disease. It comes with 63.9% with male and 83.2% with female of  
those two top subtypes. The figure 15 is a pyramid plot of  top 5 asthma 
diagnoses by gender over years and so as the table J in appendix.  
 
Average Length of  Stay of  Top 5 Prevalent Subtypes 
 We applied the average length of  stay of  top 5 symptoms of  asthma 
26 
 
discharges. As result, females has longer average hospitalization days than 
males in all the five subtypes. 493.22 has the longest hospitalization days both 
males and females and also the largest percentage compared with other 4 
symptoms. The figure 16 is a bar plot of  this result and the precise number 
are given in table K in appendix. 
We also test if  the average length of  stay has any difference between 
those top 5 prevalent subtypes. We applied ANOVA table and tested the top 
5 symptoms, gender wise, and the interaction of  top 5 symptoms and gender 
wise. As table 6, we find out that there is a significant difference between 
those three testing subjects. We further tested the group difference via LSD 
method. Table 7 indicates that 493.92 and 493.90 have no difference between 
each other.  
 
Average Charges of  Top 5 Prevalent Subtypes 
Figure 17 indicates the average cost of  those top 5 symptoms. It points 
out that 493.22 costs most among the five diagnoses. It accounts for a large 
proportion of  all asthma subtypes, roughly 30%. Also, 493.22 are gradually 
increasing from years 2006 to 2012. Females’ hospitalization charges are more 
expansive than males cost in all the five subtypes. The actual number are 
shown in the table L in appendix. 
 
Asthma Distribution by Admission Type over Years 
We want to check the admission type of  asthma discharges. NIS data 
recorded patients into two groups, elective and non-elective. Non-elective 
indicates the following type of  admission: emergency, urgent, newborn, 
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delivery, and trauma center [16]. We find out that 93.1% of  males’ and 92.7 
of  females’ admission came from the non-elective type. It shows that asthma 
is an acute, unexpected disease, which cannot make an appointment forward. 
Figure 18 shows the result of  this analysis and the actual number are shown 
in the table M in appendix. 
 
Age Distribution of  Asthma Discharges by Race over years 
We determined to find the percentage of  the age distribution of  asthma 
discharges by race. HCUP records 6 groups of  race in NIS data, White, Black, 
Hispanic, Asian or Pacific Islander, native America and others [17]. We 
separated all cases into two groups, children (less than 18) and adults (more 
than 18). For children, White and Black kids outnumber other race of  kids 
for both male and female, the percentage is 68.6% for male and 69% for 
female. When it comes to adult, white female is 55.8% over all female adult 
and as the highest rate of  all asthma discharges. Figure 19 is a pyramid plot 
of  age distribution of  asthma discharges by race over years 2006 to 2012. The 
actual number is given in the table N in appendix. 
 
Primary Expect Payer of  Asthma Discharges by Race 
Continuing the previous section, we determined to find out the primary 
expect payer of  asthma discharges by race. HCUP recorded 6 different groups, 
Medicare, Medicaid, Private Insurance, Self-Pay, No Charge and Others [18]. 
Medicaid plays the most important roles, roughly 30.7%. At the percentage 
plot, we find out that White patient has highest rate in most the payment 
methods except Medicaid. Figure 20 is a bar plot of  this section and the 
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precise number are given in table O in appendix. 
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Conclusion and Future Perspective 
We have estimated the total discharges for the entire nation from 2006 to 
2012. We focus on admissions due to asthma for the year 2006 to 2012 and 
estimate the total discharges, length of  stay, and total charges of  asthma for 
the entire nation. We observe a great imbalance in gender distribution. We 
also examined the age distribution and gender ×  age distribution for asthma. 
Similar investigation was also conducted on the top 5 prevalent subtypes of  
asthma.  
Our present thesis only focuses on discharges, length of  stay, total 
charges, gender distribution, and gender ×  age distribution. There are more 
than 250 variables in the data. Future investigation may move forward on 
other interesting variables and extract the information needed.  
In our present work, we focus only on the top 5 prevalent asthma 
subtypes based on the variable DX1 as the principle diagnosis. The data 
provide DX2-DX25 as the secondary diagnosis and beyond. Further analysis 
of  the sequential diagnosis of  DXs will help identify the relationships 
between different diseases. For example, we may elucidate the types of  
comorbidities and complications along with asthma.  
There is a limitation in our study. We can only check the hospital identical 
number from the NIS data. We cannot considered the case where the same 
person had multiple admissions and multiple discharges. In that situation, may 
lead some multiple adjustment problems. 
More and more people are suffering from asthma due to climate change 
and environmental factors. It is believed that this study will provide pointers 
that may help to manage asthma. Statistics alone cannot be a panacea to 
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alleviate pain, but the analysis of  the problem is the starting point for its 
solution. In conclusion, our study will approach asthma in several different 
angles and provide greater understanding of  this disease. 
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Table 1: Years prevalence of  asthma averaged over the years 2006 -12. 
 
Group 
Prevalence of  Asthma 
Prevalence 
(Percent) 
Prevalence 
(Number) 
95% CI 
(Percent) 
95% CI 
(number) 
All 8.454 25,942,654 (8.394158 - 
8.51373) 
(25,759,539 - 
26,125,771) 
Males 7.120 10,757,230 (7.033546 - 
7.20703) 
(10,626,202 - 
10,887,996) 
Females 9.776 15,228,896 (9.691255 - 
9.86023) 
(15,097,757 - 
15,360,352) 
Adults (≧18) 8.453 19,672,864 (8.397778 - 
8.50903) 
(19,516,534 - 
19,829,247) 
Male Adults 6.288 7,115,255 (6.191740 - 
6.38393) 
(7,006,819 - 
7,223,691) 
Female Adults 10.504 12,557,609 (10.40739 - 
10.6003) 
(12,442,504 - 
12,673,041) 
Children(<18) 8.456 6,313,262 (8.327137 - 
8.58413) 
(6,217,995 - 
6,408,529) 
Male Children 9.602 3,641,975 (9.408868 - 
9.794238) 
(3,568,890 - 
3,715,059) 
Female Children 7.375 2,671,287 (7.201177 - 
7.54843) 
(2,608,389 - 
2,734,184) 
 
  
32 
 
Table 2: Percentage of  asthmatics discharged from hospitals averaged over 
the years 2006 – 2012. 
Group Discharges 
relative to  
prevalence 
percentage 
Standard  
Error 
95% CI 
 
All 1.6787 0.02745 (1.6248 – 1.7324) 
Males 1.5249 0.03077 (1.4645 – 1.5852) 
Females 1.7538 0.02869 (1.6975 – 1.8100) 
Adults (≧18) 1.5884 0.02815 (1.5332 – 1.6435) 
Male Adults 1.1936 0.02406 (1.1464 – 1.2407) 
Female Adults 1.7467 0.03179 (1.6843 – 1.8090) 
Children (<18) 1.9482 0.07102 (1.8090 – 2.0874) 
Male Children 2.1722 0.07805 (2.0192 – 2.3251) 
Female Children 1.7871 0.06648 (1.6567 – 1.9173) 
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Table 3: Number of  states that participated in the HCUP data of  NIS. 
Year Participated States Number 
of  States 
Number of  
Hospotals 
2006 AR AZ CA CO CT FL GA HI IA IL IN KS KY MA 
MD MI MN MO NC NE NH NJ NV NY OH OK OR 
RI SC SD TN TX UT VA VT WA WI WV 
38 1,045 
2007 
AR AZ CA CO CT FL GA HI IA IL IN KS KY MA 
MD ME MI MN MO NC NE NH NJ NV NY OH OK 
OR RI SC SD TN TX UT VA VT WA WI WV WY 
40 1,044 
2008 
AR AZ CA CO CT FL GA HI IA IL IN KS KY LA 
MA MD ME MI MN MO NC NE NH NJ NV NY OH 
OK OR PA RI SC SD TN TX UT VA VT WA WI WV 
WY 
42 1,056 
2009 
AR AZ CA CO CT FL GA HI IA IL IN KS KY LA 
MA MD ME MI MN MO MT NC NE NH NJ NM 
NV NY OH OK OR PA RI SC SD TN TX UT VA VT 
WA WI WV WY 
44 1,050 
2010 
AK AR AZ CA CO CT FL GA HI IA IL IN KS KY 
LA MA MD ME MI MN MO MS MT NC NE NJ NM 
NV NY OH OK OR PA RI SC SD TN TX UT VA VT 
WA WI WV WY 
45 1,051 
2011 
AK AR AZ CA CO CT FL GA HI IA IL IN KS KY 
LA MA MD ME MI MN MO MS MT NC ND NE NJ 
NM NV NY OH OK OR PA RI SC SD TN TX UT 
VA VT WA WI WV WY 
46 1,049 
2012 
AK AR AZ CA CO CT FL GA HI IA IL IN KS KY 
LA MA MD MI MN MO MT NC ND NE NJ NM NV 
NY OH OK OR PA RI SC SD TN TX UT VA VT WA 
WI WV WY 
44 4,378 
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Table 4: Two sample t test of  length of  stay by gender wise over years. 
Two Sample T Test of  Length of  Stay by Gender wise 
  The T Test Procedure 
  Difference: Male - Female 
N Mean Std Dev Std Err Minimum Maximum 
7 -0.8088 0.0302 0.0114 -0.8545 -0.7715 
Mean 95% CL Mean Std Dev 95% CL Std Dev 
-0.8988 -0.8368 -0.7809 0.0302 0.0195 0.0665 
 DF t Value Pr < |t|   
 6 -70.87 <.0001   
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Table 5: Brief  description of  the top 5 prevalent asthma coded by ICD-9 
ICD-9 code Disease 
493.92 Asthma, unspecified type, with (acute) exacerbation 
493.22 Chronic obstructive asthma with (acute) exacerbation 
493.91 Asthma, unspecified type, with status asthmaticus 
493.90 Asthma, unspecified type, unspecified 
493.02 Extrinsic asthma with (acute) exacerbation 
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Table 6: The ANOVA of  length of  Stay by gender wise of  top 5 prevalent 
asthma. 
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Table 7: The LSD test for average length of  stay for top 5 prevalent asthma. 
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Figure 1: Asthma prevalence through 2006 to 2012. 
 
39 
 
 
Figure 2: Asthma prevalence among males over years 2006 – 2012. 
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Figure 3: Asthma prevalence among females over years. 
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Figure 4: Asthma prevalence among children over years. 
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Figure 5: Asthma prevalence among adult over years. 
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Figure 6: Asthma prevalence among male children over years. 
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Figure 7: Asthma prevalence among female children over years. 
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Figure 8: The fitting plot of  log discharges for year 2008. 
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Figure 9: The total number of  asthma discharges over years. 
  
Year
2006 459088.1658
2007 437467.3654
2008 420544.3663
2009 460819.4967
2010 426354.3158
2011 389070.7291
2012 454055.2863
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Figure 10: Gender distribution of  asthma discharges over years. 
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Figure 11: Distribution of  age asthma discharges by gender. 
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Figure 12: Distribution of  age asthma discharges by children and adult. 
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Figure 13: Average length of  stay by gender over years. 
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Figure 14: Average charges by gender over years. 
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Figure 15: Top 5 asthma diagnoses by gender over years 2006 to 2012. 
  
53 
 
 
Figure 16: Average length of  stay of  top 5 prevalent subtypes over years 
2006 to 2012. 
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Figure 17: Average charges of  top 5 prevalent subtypes over years 2006 to 
2012. 
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Figure 18: Asthma Distribution by Admission Type over years 2006 to 2012. 
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Figure 19: Age Distribution of  asthma discharge by race over years 2006 to 
2012. 
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Figure 20: Primary expect payer of  asthma by race over years 2006 to 2012. 
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Year
State
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
AK 8.935 0.657 7.771 0.606 8.911 0.926 8.811 0.846 9.312 1.013 7.979 0.774 8.739 0.617
AL 8.653 0.565 8.640 0.482 7.898 0.475 7.593 0.421 8.551 0.403 8.011 0.407 8.505 0.387
AR 7.714 0.395 7.294 0.398 8.210 0.474 7.619 0.552 7.797 0.557 9.136 0.588 8.621 0.458
AZ 8.392 0.680 8.084 0.579 9.185 0.800 9.966 0.729 10.542 0.654 9.298 0.586 8.627 0.450
CA 7.718 0.379 7.705 0.394 8.121 0.296 7.506 0.250 7.196 0.255 8.442 0.277 8.876 0.295
CO 7.815 0.387 7.749 0.323 8.037 0.333 8.048 0.357 8.955 0.410 8.210 0.338 8.773 0.337
CT 9.077 0.389 9.436 0.462 9.242 0.525 9.829 0.525 9.376 0.468 10.120 0.507 10.167 0.426
DC 9.169 0.589 10.412 0.606 9.895 0.611 10.391 0.636 11.428 0.685 9.246 0.848 9.817 0.814
DE 9.359 0.599 8.047 0.548 9.121 0.788 9.730 0.619 9.443 0.696 9.310 0.712 9.458 0.568
FL 7.297 0.348 6.594 0.276 7.111 0.387 7.109 0.380 8.179 0.336 7.707 0.335 8.267 0.443
GA 7.841 0.388 7.913 0.353 9.293 0.562 7.658 0.498 8.193 0.472 9.208 0.401 8.284 0.446
HI 8.031 0.415 9.028 0.458 10.284 0.476 9.681 0.456 9.171 0.443 9.613 0.468 9.178 0.444
IA 6.971 0.367 6.526 0.378 7.406 0.394 6.277 0.356 7.336 0.411 8.253 0.429 8.120 0.399
ID 8.792 0.425 8.600 0.492 7.908 0.465 7.303 0.423 8.629 0.519 8.903 0.571 8.363 0.540
IL 8.241 0.444 8.159 0.451 8.004 0.416 9.083 0.479 9.393 0.561 8.233 0.445 8.526 0.504
IN 8.255 0.360 8.466 0.436 8.880 0.497 9.141 0.414 9.151 0.374 9.237 0.389 8.876 0.358
KS 8.275 0.338 8.292 0.373 8.630 0.365 8.296 0.267 8.180 0.375 8.607 0.347 8.368 0.322
KY 8.164 0.436 8.802 0.478 9.450 0.440 9.593 0.503 10.270 0.492 9.895 0.433 10.422 0.414
LA 6.762 0.357 6.765 0.407 8.050 0.450 6.950 0.343 6.917 0.411 6.839 0.362 7.674 0.397
MA 9.386 0.392 9.743 0.348 9.381 0.339 10.148 0.416 10.036 0.378 10.088 0.349 10.257 0.322
MD 8.651 0.410 8.418 0.363 9.400 0.397 9.609 0.450 8.897 0.421 8.358 0.404 8.861 0.393
ME 9.494 0.491 9.930 0.445 10.092 0.429 10.543 0.443 9.505 0.417 11.177 0.510 10.423 0.429
MI 9.166 0.432 9.580 0.428 10.053 0.401 9.548 0.394 10.578 0.437 9.816 0.384 10.256 0.368
MN 7.922 0.448 7.923 0.475 7.909 0.468 6.869 0.423 7.674 0.541 7.273 0.317 8.048 0.324
MO 8.487 0.543 8.449 0.489 8.691 0.513 8.980 0.588 9.194 0.562 8.944 0.437 9.927 0.489
MS 7.381 0.392 7.554 0.360 7.402 0.353 8.181 0.344 7.501 0.348 7.791 0.422 8.149 0.388
MT 8.282 0.414 8.665 0.458 8.778 0.449 7.687 0.390 8.463 0.490 8.484 0.387 8.787 0.405
NC 6.992 0.296 7.809 0.344 7.710 0.302 7.692 0.353 7.526 0.354 8.681 0.388 7.869 0.321
ND 7.387 0.519 7.946 0.527 7.257 0.450 7.987 0.506 6.808 0.487 7.838 0.742 7.569 0.577
NE 7.718 0.401 8.119 0.498 6.826 0.368 6.926 0.391 7.231 0.383 7.481 0.387 7.564 0.241
NH 9.379 0.414 9.621 0.448 9.958 0.445 9.810 0.569 9.888 0.570 10.299 0.600 9.740 0.480
NJ 7.794 0.310 8.940 0.496 8.625 0.353 7.940 0.322 8.617 0.337 8.793 0.320 8.583 0.295
NM 8.399 0.433 8.588 0.441 8.217 0.443 8.443 0.407 8.965 0.507 9.908 0.373 9.432 0.326
NV 7.700 0.572 6.595 0.475 8.125 0.563 8.524 0.742 8.807 0.725 7.995 0.529 7.513 0.453
NY 8.284 0.424 9.277 0.425 9.087 0.410 9.621 0.450 9.239 0.443 9.360 0.406 9.072 0.457
OH 9.284 0.709 8.769 0.378 9.409 0.362 8.531 0.401 9.377 0.518 9.511 0.391 10.027 0.333
OK 8.672 0.358 9.024 0.367 9.051 0.372 10.013 0.478 9.430 0.391 9.220 0.436 9.724 0.379
OR 9.339 0.462 9.234 0.504 7.830 0.439 10.610 0.621 9.004 0.543 10.073 0.473 10.256 0.500
PA 8.615 0.408 9.533 0.480 9.234 0.387 9.149 0.426 9.551 0.359 9.108 0.347 10.008 0.319
RI 10.310 0.553 9.690 0.570 10.954 0.561 10.154 0.471 10.856 0.538 10.978 0.636 10.174 0.564
SC 7.676 0.365 7.598 0.372 8.136 0.423 7.736 0.410 8.152 0.529 8.180 0.367 8.564 0.358
SD 7.821 0.433 7.366 0.493 7.230 0.594 7.841 0.642 7.719 0.646 7.093 0.664 7.559 0.523
TN 8.313 0.501 8.509 0.504 8.742 0.486 7.985 0.460 5.990 0.526 7.553 0.856 7.944 0.432
TX 7.394 0.572 8.298 0.319 7.662 0.366 6.763 0.337 7.267 0.353 7.447 0.306 7.141 0.346
UT 8.107 0.416 7.590 0.394 7.529 0.441 7.599 0.314 8.512 0.395 8.073 0.283 8.117 0.281
VA 8.284 0.534 7.865 0.432 9.182 0.661 7.837 0.543 8.155 0.563 8.589 0.452 8.670 0.387
VT 9.161 0.387 9.208 0.449 9.858 0.421 9.851 0.430 10.706 0.482 10.380 0.461 10.254 0.621
WA 8.633 0.300 8.998 0.292 9.041 0.288 8.177 0.239 8.606 0.263 8.946 0.355 9.045 0.281
WI 8.625 0.527 8.865 0.512 8.838 0.519 9.015 0.646 8.327 0.547 8.748 0.537 8.282 0.546
WV 8.597 0.515 9.270 0.503 9.983 0.514 8.638 0.450 6.913 0.426 8.775 0.465 9.638 0.437
WY 8.710 0.423 8.233 0.524 8.202 0.357 8.702 0.759 8.583 0.445 8.698 0.854 8.641 0.547
2012
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Table A: The percentages of  asthma prevalence along with standard error 
state by state over 2006 to 2012. 
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Table B-1: The percentages of  asthma prevalence among male with standard 
error state by state over 2006 to 2012. 
  
Year
State
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
AK 5.332 0.737 5.195 0.755 7.733 1.349 6.538 1.162 7.075 1.304 6.009 1.195 6.085 0.813
AL 6.853 0.810 7.585 0.781 6.800 0.692 6.781 0.688 6.587 0.572 6.955 0.631 7.678 0.557
AR 6.691 0.586 6.063 0.589 7.684 0.723 6.327 0.833 6.327 0.770 7.461 0.865 7.291 0.630
AZ 7.264 0.841 6.779 0.798 9.118 1.377 9.657 1.197 9.536 1.023 7.696 0.805 6.962 0.605
CA 6.636 0.524 6.514 0.580 6.833 0.430 5.952 0.355 6.190 0.373 7.024 0.388 6.804 0.385
CO 7.116 0.570 6.572 0.466 7.309 0.507 6.960 0.533 7.410 0.567 7.510 0.525 7.797 0.479
CT 7.751 0.547 7.572 0.702 8.224 0.835 8.615 0.790 8.065 0.700 7.937 0.663 8.354 0.584
DC 8.861 0.940 8.550 0.891 7.554 0.878 8.837 0.905 10.702 1.097 7.513 1.486 7.991 1.014
DE 8.948 0.959 6.202 0.860 7.311 1.295 8.825 0.940 7.966 1.075 5.980 1.090 7.445 0.845
FL 6.344 0.542 5.965 0.416 6.509 0.637 5.888 0.592 7.089 0.537 6.255 0.492 6.251 0.531
GA 6.982 0.579 6.056 0.488 7.757 0.904 7.250 0.817 6.936 0.737 7.948 0.605 7.032 0.600
HI 7.747 0.570 8.349 0.732 9.467 0.696 7.953 0.622 7.544 0.605 7.991 0.612 6.929 0.546
IA 5.585 0.562 4.987 0.510 7.008 0.620 5.624 0.554 6.480 0.656 7.163 0.628 7.063 0.527
ID 7.798 0.658 7.437 0.785 7.360 0.738 6.681 0.643 7.981 0.809 7.888 0.896 7.419 0.759
IL 6.827 0.669 6.982 0.676 6.321 0.571 7.138 0.653 7.744 0.835 6.782 0.653 7.730 0.711
IN 6.612 0.522 6.343 0.566 7.225 0.764 7.549 0.581 7.283 0.538 6.965 0.524 7.633 0.523
KS 7.001 0.501 7.112 0.543 7.805 0.523 7.431 0.406 6.920 0.562 7.087 0.540 7.808 0.464
KY 7.042 0.632 8.524 0.791 7.188 0.630 8.573 0.796 8.788 0.756 7.645 0.592 9.206 0.611
LA 5.231 0.495 6.577 0.700 7.119 0.681 5.817 0.535 6.183 0.700 5.524 0.555 6.744 0.600
MA 8.228 0.619 8.354 0.542 8.038 0.507 8.234 0.598 8.517 0.569 8.171 0.504 8.293 0.443
MD 7.979 0.651 6.640 0.495 8.044 0.586 8.500 0.640 7.779 0.646 7.231 0.627 7.456 0.535
ME 7.706 0.686 8.024 0.635 7.829 0.592 8.388 0.653 7.016 0.567 8.527 0.821 8.937 0.654
MI 7.257 0.609 8.959 0.640 8.311 0.606 7.719 0.566 9.102 0.634 8.073 0.527 8.101 0.499
MN 6.594 0.644 6.802 0.726 7.108 0.685 6.297 0.675 6.530 0.751 5.995 0.459 7.198 0.466
MO 7.693 0.830 7.807 0.728 7.934 0.710 7.944 0.949 7.785 0.823 7.272 0.621 8.985 0.723
MS 7.206 0.615 6.744 0.560 6.908 0.545 6.810 0.498 6.088 0.491 6.484 0.646 7.551 0.557
MT 6.950 0.631 8.189 0.733 7.357 0.600 6.494 0.544 7.178 0.622 6.705 0.493 7.698 0.574
NC 5.716 0.438 7.248 0.563 6.500 0.450 6.316 0.504 6.234 0.541 6.762 0.549 6.513 0.478
ND 6.359 0.736 6.983 0.935 6.884 0.670 5.657 0.545 5.822 0.723 6.903 1.232 7.267 0.880
NE 5.930 0.641 7.909 0.782 6.539 0.572 5.981 0.533 6.165 0.517 6.758 0.632 6.584 0.349
NH 7.410 0.597 7.142 0.668 7.200 0.579 8.009 0.827 8.064 0.822 8.523 0.932 7.629 0.629
NJ 6.932 0.433 8.329 0.839 7.406 0.536 5.988 0.459 7.452 0.524 7.430 0.456 7.297 0.419
NM 7.291 0.615 8.024 0.713 7.454 0.732 7.840 0.645 8.158 0.808 8.304 0.533 7.557 0.457
NV 6.138 0.674 4.836 0.604 6.766 0.820 7.292 1.133 7.194 1.031 7.028 0.806 5.034 0.533
NY 7.396 0.613 7.801 0.623 7.132 0.564 7.904 0.664 7.884 0.696 7.493 0.555 7.243 0.618
OH 7.835 1.021 7.610 0.609 8.014 0.517 7.124 0.607 7.565 0.743 7.744 0.565 8.009 0.462
OK 7.512 0.545 7.355 0.530 7.633 0.558 8.525 0.731 8.281 0.598 7.806 0.674 7.876 0.546
OR 8.028 0.693 7.050 0.720 5.804 0.582 10.082 0.978 7.451 0.759 7.628 0.606 7.730 0.680
PA 6.477 0.543 8.077 0.776 7.842 0.560 7.685 0.616 8.363 0.567 7.962 0.521 8.015 0.447
RI 9.168 0.814 6.912 0.845 9.639 0.874 8.001 0.626 8.368 0.805 8.678 1.044 9.226 0.888
SC 6.703 0.542 6.775 0.608 6.224 0.562 6.363 0.580 7.264 0.890 6.568 0.537 7.393 0.527
SD 7.867 0.640 6.864 0.891 6.762 0.911 6.720 0.947 7.548 0.977 5.884 1.072 7.165 0.802
TN 7.777 0.821 7.183 0.703 6.936 0.667 7.398 0.760 5.197 0.843 6.962 1.497 6.909 0.684
TX 6.305 0.640 7.362 0.492 7.450 0.610 5.890 0.507 6.086 0.519 6.025 0.419 5.828 0.442
UT 6.708 0.549 6.770 0.553 6.900 0.559 7.221 0.471 7.418 0.497 7.015 0.382 6.978 0.385
VA 6.843 0.730 6.779 0.648 7.077 1.059 6.717 0.840 6.216 0.658 6.046 0.515 6.905 0.536
VT 7.592 0.522 7.311 0.693 8.876 0.649 8.047 0.593 8.228 0.678 8.951 0.654 7.452 0.891
WA 7.148 0.450 7.443 0.433 7.503 0.417 6.955 0.334 7.078 0.391 7.245 0.495 6.912 0.372
WI 7.339 0.837 7.829 0.774 8.273 0.819 7.803 0.992 6.747 0.706 7.865 0.797 7.553 0.822
WV 6.175 0.639 7.727 0.703 7.866 0.679 6.407 0.632 5.297 0.569 6.673 0.684 7.551 0.592
WY 7.219 0.599 7.851 1.011 7.607 0.536 7.838 1.162 7.331 0.612 7.618 1.413 7.315 0.782
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Table B-2: The percentages of  asthma prevalence among female with 
standard error state by state over 2006 to 2012. 
  
Year
State
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
AK 11.966 1.140 9.770 0.989 10.302 1.315 11.285 1.266 11.861 1.623 10.224 0.944 12.189 0.968
AL 10.429 0.811 9.685 0.597 8.955 0.663 8.456 0.514 10.385 0.583 8.986 0.528 10.391 0.555
AR 8.732 0.548 8.494 0.552 8.756 0.634 8.941 0.745 9.283 0.820 10.765 0.819 10.142 0.683
AZ 10.333 1.097 9.254 0.858 9.235 0.863 10.410 0.866 11.519 0.856 10.881 0.878 10.079 0.684
CA 9.026 0.562 8.896 0.550 9.410 0.417 9.062 0.359 8.190 0.355 9.668 0.403 10.688 0.455
CO 8.621 0.539 9.004 0.457 8.802 0.443 9.263 0.485 10.567 0.606 8.889 0.428 9.889 0.488
CT 10.392 0.568 11.033 0.620 10.168 0.670 10.986 0.716 10.555 0.643 12.176 0.778 12.081 0.636
DC 11.039 0.764 12.073 0.854 11.979 0.870 11.720 0.914 12.037 0.883 10.891 0.889 13.357 1.282
DE 9.653 0.774 9.706 0.745 10.904 0.954 10.563 0.841 10.924 0.924 12.525 0.916 11.807 0.791
FL 8.427 0.454 7.351 0.373 7.684 0.458 8.433 0.493 9.246 0.424 9.002 0.465 10.085 0.714
GA 9.319 0.533 9.669 0.521 10.651 0.694 7.934 0.590 9.391 0.614 10.336 0.545 10.496 0.676
HI 10.270 0.623 9.719 0.571 11.102 0.673 11.439 0.688 10.782 0.666 11.238 0.725 11.546 0.716
IA 7.329 0.488 8.013 0.567 7.793 0.507 6.916 0.465 8.121 0.513 9.336 0.590 9.379 0.611
ID 8.452 0.558 9.749 0.621 8.436 0.582 7.929 0.564 9.375 0.676 9.975 0.707 9.689 0.793
IL 9.819 0.603 9.299 0.616 9.629 0.621 10.970 0.714 10.953 0.775 9.540 0.620 9.524 0.729
IN 9.884 0.514 10.526 0.676 10.435 0.665 10.645 0.604 10.912 0.534 11.394 0.583 10.123 0.505
KS 9.838 0.468 9.450 0.525 9.437 0.524 9.146 0.356 9.402 0.510 10.118 0.432 9.890 0.461
KY 9.568 0.619 9.118 0.568 11.623 0.633 10.671 0.639 11.704 0.654 12.064 0.639 12.375 0.582
LA 8.293 0.521 6.998 0.448 8.960 0.610 7.989 0.446 7.608 0.456 8.079 0.470 8.703 0.537
MA 10.583 0.506 11.048 0.463 10.612 0.468 11.946 0.595 11.412 0.516 11.857 0.490 12.159 0.478
MD 9.687 0.525 10.089 0.542 10.669 0.554 10.647 0.647 9.935 0.564 9.383 0.528 10.881 0.587
ME 11.176 0.722 11.747 0.644 12.244 0.639 12.599 0.622 11.832 0.624 13.784 0.611 12.170 0.584
MI 11.220 0.630 10.181 0.588 11.739 0.544 11.318 0.563 11.978 0.618 11.462 0.574 11.985 0.557
MN 8.517 0.640 9.099 0.630 8.726 0.654 7.542 0.524 8.856 0.792 8.505 0.439 8.988 0.464
MO 9.775 0.726 9.061 0.677 9.414 0.759 10.081 0.733 10.546 0.791 10.517 0.627 11.505 0.687
MS 8.372 0.509 8.317 0.473 7.856 0.466 9.440 0.488 8.812 0.504 9.033 0.549 9.358 0.559
MT 8.564 0.552 9.054 0.571 10.186 0.682 8.882 0.575 9.760 0.774 10.278 0.609 10.338 0.589
NC 8.374 0.409 8.457 0.415 8.875 0.414 9.142 0.506 8.795 0.472 10.436 0.559 9.149 0.441
ND 8.295 0.773 8.814 0.617 7.634 0.614 10.340 0.867 7.815 0.662 8.906 0.789 8.486 0.774
NE 8.527 0.505 8.324 0.642 7.076 0.477 7.853 0.582 8.271 0.578 8.237 0.432 7.888 0.342
NH 11.513 0.594 11.997 0.621 12.620 0.689 11.598 0.807 11.747 0.815 12.098 0.762 12.655 0.741
NJ 9.761 0.452 9.499 0.572 9.722 0.475 9.775 0.460 9.700 0.443 10.034 0.458 9.790 0.424
NM 9.478 0.628 9.139 0.547 8.953 0.525 9.034 0.518 9.728 0.636 11.477 0.541 9.906 0.477
NV 8.530 0.951 8.419 0.753 9.537 0.798 9.644 0.971 10.435 1.049 8.997 0.686 9.074 0.748
NY 10.228 0.604 10.669 0.601 10.850 0.602 11.239 0.627 10.510 0.576 11.010 0.603 10.715 0.683
OH 10.570 1.017 9.871 0.473 10.726 0.523 9.872 0.547 11.020 0.743 11.122 0.554 11.811 0.493
OK 9.759 0.484 10.653 0.526 10.410 0.510 11.467 0.640 10.557 0.526 10.602 0.564 11.558 0.544
OR 10.685 0.636 11.380 0.724 9.821 0.672 11.130 0.800 10.526 0.793 12.436 0.743 11.729 0.752
PA 10.637 0.620 10.894 0.597 10.545 0.549 10.532 0.607 10.661 0.463 10.179 0.475 12.040 0.465
RI 12.227 0.783 12.238 0.811 12.192 0.739 12.187 0.718 13.179 0.740 13.210 0.748 11.426 0.734
SC 8.678 0.504 8.431 0.452 9.979 0.640 9.138 0.593 9.047 0.610 9.691 0.505 9.820 0.502
SD 7.671 0.617 7.778 0.519 7.779 0.789 8.983 0.886 7.999 0.872 8.410 0.758 8.499 0.697
TN 8.937 0.611 9.849 0.747 10.476 0.722 8.653 0.552 6.744 0.653 8.114 0.899 8.556 0.556
TX 9.004 0.957 9.218 0.421 7.853 0.421 7.633 0.455 8.420 0.490 8.836 0.458 8.291 0.542
UT 8.188 0.643 8.421 0.579 8.145 0.696 7.957 0.428 9.566 0.625 9.119 0.428 9.646 0.421
VA 10.605 0.796 8.825 0.589 11.180 0.820 8.814 0.705 10.067 0.920 10.990 0.745 10.406 0.572
VT 10.929 0.584 11.046 0.592 10.800 0.560 11.581 0.639 13.056 0.704 11.769 0.674 13.462 0.897
WA 10.230 0.410 10.623 0.402 10.590 0.407 9.385 0.351 10.086 0.362 10.624 0.524 10.957 0.433
WI 9.443 0.663 9.887 0.697 9.334 0.662 10.211 0.858 9.834 0.851 9.618 0.748 9.053 0.750
WV 10.761 0.818 10.750 0.741 12.015 0.794 10.784 0.659 8.437 0.645 10.820 0.650 11.719 0.664
WY 10.007 0.618 8.511 0.513 8.809 0.483 9.601 0.998 9.887 0.665 9.949 0.902 10.300 0.793
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Table C-1: The percentages of  asthma prevalence among Children (under 18) 
with standard error state by state over 2006 to 2012. 
  
Year
State
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
AK 8.495 1.192 8.607 1.178 7.912 2.141 8.648 2.135 8.521 2.139 8.080 2.394 9.306 1.640
AL 8.213 0.910 8.369 0.900 8.384 0.885 7.919 0.860 11.067 1.022 8.513 0.947 11.057 0.834
AR 8.287 0.921 8.430 0.951 8.261 1.028 8.099 1.006 8.298 1.126 8.398 1.117 8.878 0.937
AZ 8.155 1.619 7.266 1.076 7.900 1.350 7.756 0.773 10.111 1.285 8.878 1.169 8.509 0.947
CA 7.892 0.809 7.886 0.761 6.835 0.508 6.171 0.475 5.711 0.636 9.051 0.692 8.594 0.604
CO 8.206 0.909 8.361 0.895 8.402 0.869 7.887 0.840 8.208 0.973 8.533 0.924 8.707 0.831
CT 8.260 0.917 9.692 0.807 10.849 1.117 11.749 1.037 10.948 1.016 11.284 1.077 11.943 0.913
DC 8.572 1.490 15.690 1.940 12.366 1.639 13.684 1.642 19.404 2.335 7.943 3.775 13.666 2.346
DE 8.479 0.995 8.591 1.283 7.946 1.951 13.488 1.315 8.506 2.022 8.099 2.253 9.276 1.556
FL 8.018 0.896 8.204 0.838 8.731 0.712 7.443 0.681 8.016 0.827 8.832 0.739 8.352 0.731
GA 8.092 0.818 9.076 0.827 11.594 1.162 9.789 1.017 9.121 0.945 8.711 0.789 10.804 1.023
HI 8.423 0.942 12.658 0.932 12.675 0.949 10.926 0.908 10.289 0.924 10.809 0.880 11.050 0.931
IA 8.284 0.687 4.804 0.567 6.084 0.613 4.675 0.594 6.067 0.777 8.403 1.108 8.872 0.933
ID 8.373 0.603 8.501 1.049 6.016 0.758 4.495 0.628 8.382 1.366 8.275 1.422 9.039 1.104
IL 8.054 0.898 7.826 0.928 8.427 0.903 9.271 0.927 9.993 1.250 8.766 0.763 9.411 1.050
IN 8.160 0.737 7.894 0.838 8.448 1.006 9.571 0.831 8.482 0.768 8.599 0.862 8.629 0.798
KS 8.287 0.653 7.922 0.611 8.762 0.637 8.073 0.418 7.257 0.616 8.403 1.108 10.398 0.757
KY 8.230 0.968 8.383 0.909 9.120 0.806 7.960 0.888 10.394 1.014 8.488 0.977 10.209 0.821
LA 8.221 0.911 8.372 0.901 8.382 0.887 9.080 0.770 8.156 0.765 8.510 0.950 8.737 0.846
MA 8.173 0.906 10.293 1.101 9.472 1.000 8.995 1.021 9.366 1.086 8.568 0.889 8.668 0.813
MD 8.182 0.742 9.023 0.824 9.395 0.728 11.730 1.003 11.529 0.953 8.556 0.900 10.158 0.803
ME 8.427 0.914 8.278 0.773 9.295 0.756 9.741 1.022 8.221 1.046 8.164 1.870 9.191 1.357
MI 8.092 0.875 9.953 0.894 10.639 0.869 8.151 0.737 10.859 0.960 9.798 0.753 9.204 0.679
MN 8.195 0.723 8.354 0.890 8.414 0.860 7.876 0.834 8.201 0.964 8.543 0.913 8.696 0.826
MO 8.176 1.088 8.268 0.866 9.776 1.142 7.828 0.807 10.740 1.326 8.568 0.889 10.156 1.070
MS 8.273 0.808 10.003 0.819 8.551 0.794 10.224 0.731 8.587 0.800 8.411 1.094 9.779 0.821
MT 8.468 0.740 6.636 0.746 6.525 0.773 6.299 0.706 6.669 0.813 6.745 0.707 7.781 0.964
NC 8.113 0.901 8.282 0.857 8.569 0.766 7.654 0.735 8.107 0.876 8.689 0.800 8.519 0.764
ND 8.535 1.039 8.640 1.487 5.360 0.724 5.636 0.705 6.070 0.810 8.028 2.816 9.368 1.840
NE 8.356 0.630 8.169 0.893 6.063 0.607 5.096 0.559 5.948 0.716 8.293 1.367 6.957 0.523
NH 8.417 0.830 7.487 0.785 8.452 0.789 8.459 1.579 8.450 1.666 8.174 1.825 10.418 0.979
NJ 8.118 0.707 10.756 1.382 8.491 0.631 8.989 0.648 8.695 0.635 8.506 0.558 8.685 0.524
NM 8.338 0.933 8.326 0.797 7.587 0.747 8.099 0.936 7.690 0.771 10.046 0.765 7.409 0.619
NV 8.299 1.141 6.037 0.830 6.901 1.006 6.987 1.410 8.620 1.523 8.381 1.152 6.371 0.900
NY 8.001 0.988 11.435 1.157 10.673 0.937 9.677 0.973 7.304 1.304 8.851 0.733 8.974 0.992
OH 8.075 1.190 8.570 0.641 9.236 0.683 4.563 0.540 8.950 1.489 8.731 0.779 8.522 0.612
OK 8.249 0.641 10.320 0.761 9.788 0.744 10.490 1.152 9.907 0.812 8.465 1.008 8.555 0.750
OR 8.254 0.916 8.045 0.889 5.334 0.780 9.250 1.178 7.402 0.939 9.405 0.987 7.297 0.923
PA 8.072 0.838 10.396 0.878 9.574 0.859 9.988 1.039 9.282 0.824 9.866 0.728 10.284 0.657
RI 8.456 0.962 8.575 1.227 12.244 1.113 10.840 0.876 11.407 0.980 8.116 2.146 9.258 1.510
SC 8.224 0.911 8.376 0.904 8.371 0.897 7.936 0.871 8.229 1.002 8.501 0.961 8.748 0.851
SD 8.485 0.999 8.597 1.301 7.935 2.005 8.613 2.012 8.509 2.039 8.097 2.268 9.277 1.560
TN 8.172 0.905 8.334 0.879 8.458 0.827 7.812 0.799 6.247 1.446 8.857 2.760 8.027 0.960
TX 7.947 1.001 8.742 0.778 8.729 0.754 7.763 0.722 7.395 0.724 8.035 0.664 7.695 0.758
UT 8.265 0.593 7.078 0.685 6.133 0.664 6.865 0.508 6.682 0.523 6.501 0.385 7.086 0.490
VA 8.139 1.052 7.670 0.762 9.304 1.085 8.194 1.119 8.140 0.902 8.637 0.833 8.582 0.782
VT 8.547 0.776 7.690 0.739 9.978 0.840 10.271 0.902 9.770 0.944 7.891 0.736 9.442 2.126
WA 8.165 0.905 8.328 0.876 8.470 0.819 6.633 0.414 5.852 0.406 7.063 0.669 6.709 0.543
WI 8.187 0.802 7.703 0.973 7.359 0.998 6.795 1.184 8.654 1.092 7.413 0.936 7.582 1.268
WV 8.378 0.950 9.871 1.035 11.220 1.204 8.177 0.928 6.368 0.846 7.579 0.891 7.727 0.802
WY 8.560 0.804 8.656 1.577 5.628 0.522 8.787 2.729 6.325 0.721 8.001 3.086 8.633 1.255
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 Table C-2: The percentages of  asthma prevalence among adult (18 and over) 
with standard error state by state over 2006 to 2012. 
  
Year
State
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
Prevalence
Percent
Standard
Error
AK 9.099 0.784 7.465 0.706 9.266 0.997 8.870 0.858 9.594 1.143 7.944 0.621 8.945 0.608
AL 8.795 0.688 8.727 0.568 7.743 0.559 7.491 0.483 7.769 0.422 7.857 0.445 8.490 0.436
AR 7.525 0.429 6.920 0.427 8.193 0.531 7.462 0.655 7.635 0.641 9.371 0.688 8.692 0.525
AZ 8.477 0.717 8.380 0.686 9.647 0.974 10.753 0.949 10.688 0.759 9.438 0.677 8.550 0.510
CA 7.656 0.426 7.641 0.460 8.567 0.357 7.963 0.293 7.688 0.266 8.243 0.289 8.811 0.338
CO 7.686 0.419 7.548 0.313 7.919 0.340 8.100 0.386 9.195 0.442 8.107 0.335 8.855 0.358
CT 9.332 0.423 9.357 0.551 8.756 0.595 9.256 0.607 8.912 0.527 9.782 0.575 9.803 0.482
DC 9.315 0.637 9.138 0.589 9.309 0.648 9.617 0.684 9.830 0.676 9.512 0.670 10.277 0.854
DE 9.636 0.723 7.877 0.597 9.484 0.836 8.582 0.702 9.720 0.676 9.663 0.644 9.849 0.579
FL 7.088 0.367 6.131 0.261 6.652 0.454 7.015 0.448 8.223 0.364 7.408 0.376 8.122 0.525
GA 7.750 0.437 7.491 0.376 8.465 0.639 6.899 0.569 7.872 0.545 9.377 0.466 8.145 0.487
HI 7.915 0.460 7.958 0.526 9.589 0.549 9.321 0.526 8.850 0.505 9.274 0.546 8.712 0.505
IA 6.557 0.431 7.067 0.464 7.818 0.480 6.776 0.429 7.734 0.482 8.206 0.444 8.026 0.436
ID 8.950 0.539 8.638 0.550 8.616 0.572 8.348 0.531 8.721 0.496 9.135 0.578 8.387 0.618
IL 8.305 0.511 8.270 0.515 7.865 0.467 9.021 0.559 9.200 0.622 8.064 0.533 8.423 0.574
IN 8.287 0.413 8.658 0.509 9.023 0.572 8.999 0.478 9.371 0.427 9.445 0.433 8.951 0.397
KS 8.271 0.394 8.416 0.454 8.586 0.438 8.371 0.328 8.495 0.457 8.676 0.275 8.352 0.347
KY 8.143 0.485 8.933 0.559 9.553 0.519 10.095 0.598 10.232 0.562 10.326 0.480 10.997 0.479
LA 6.273 0.365 6.223 0.452 7.939 0.523 6.240 0.379 6.514 0.484 6.299 0.368 7.405 0.448
MA 9.739 0.432 9.585 0.317 9.356 0.331 10.469 0.449 10.220 0.378 10.501 0.373 10.694 0.346
MD 8.803 0.487 8.224 0.400 9.402 0.469 8.949 0.500 8.094 0.467 8.298 0.451 8.945 0.451
ME 9.788 0.573 10.377 0.526 10.303 0.504 10.751 0.491 9.838 0.450 11.945 0.427 10.958 0.415
MI 9.518 0.496 9.460 0.487 9.869 0.451 9.979 0.462 10.491 0.489 9.822 0.445 10.349 0.433
MN 7.833 0.546 7.784 0.559 7.748 0.553 6.551 0.490 7.506 0.644 6.873 0.302 7.888 0.339
MO 8.588 0.627 8.507 0.583 8.346 0.571 9.342 0.730 8.712 0.610 9.060 0.502 10.320 0.549
MS 7.064 0.446 6.683 0.392 6.996 0.386 7.463 0.387 7.131 0.379 7.583 0.428 8.049 0.439
MT 8.225 0.491 9.271 0.552 9.441 0.534 8.091 0.460 8.985 0.587 8.983 0.456 9.361 0.442
NC 6.630 0.262 7.656 0.360 7.432 0.314 7.704 0.403 7.344 0.375 8.678 0.444 7.621 0.348
ND 7.052 0.599 7.746 0.526 7.802 0.540 8.660 0.618 7.019 0.581 7.784 0.516 7.482 0.526
NE 7.501 0.493 8.102 0.593 7.083 0.447 7.540 0.487 7.661 0.452 7.209 0.241 7.334 0.269
NH 9.669 0.477 10.247 0.532 10.389 0.525 10.187 0.580 10.287 0.563 10.874 0.582 10.109 0.549
NJ 7.691 0.341 8.368 0.485 8.667 0.419 7.617 0.370 8.593 0.396 8.879 0.381 8.584 0.350
NM 8.420 0.486 8.678 0.525 8.433 0.537 8.560 0.442 9.393 0.625 9.862 0.427 9.215 0.382
NV 7.491 0.661 6.791 0.572 8.553 0.673 9.058 0.871 8.868 0.824 7.871 0.592 7.247 0.524
NY 8.371 0.463 8.627 0.430 8.616 0.453 9.604 0.507 9.793 0.430 9.503 0.478 9.115 0.515
OH 9.670 0.855 8.832 0.455 9.463 0.424 9.751 0.498 9.509 0.497 9.749 0.452 10.388 0.391
OK 8.814 0.426 8.593 0.419 8.807 0.429 9.855 0.509 9.274 0.446 9.467 0.476 10.148 0.440
OR 9.670 0.534 9.593 0.598 8.577 0.521 11.012 0.725 9.471 0.645 10.264 0.539 10.490 0.586
PA 8.774 0.467 9.282 0.564 9.136 0.433 8.913 0.461 9.626 0.397 8.898 0.395 10.021 0.364
RI 10.845 0.657 10.007 0.644 10.594 0.647 9.966 0.550 10.707 0.630 11.735 0.570 10.675 0.592
SC 7.501 0.384 7.351 0.397 8.062 0.478 7.674 0.465 8.128 0.619 8.084 0.380 8.590 0.390
SD 7.600 0.471 6.959 0.495 6.999 0.437 7.589 0.542 7.458 0.533 6.764 0.475 7.396 0.473
TN 8.358 0.594 8.565 0.602 8.831 0.583 8.038 0.550 5.911 0.526 7.156 0.735 7.670 0.482
TX 7.180 0.693 8.127 0.324 7.250 0.416 6.377 0.375 7.219 0.402 7.229 0.340 6.838 0.383
UT 8.036 0.542 7.822 0.481 8.162 0.566 7.931 0.395 9.351 0.524 8.789 0.373 8.872 0.342
VA 8.330 0.619 7.926 0.514 9.144 0.797 7.727 0.621 8.160 0.680 8.575 0.532 8.682 0.445
VT 9.330 0.444 9.615 0.534 9.827 0.483 9.744 0.488 10.949 0.556 11.008 0.546 10.800 0.570
WA 8.781 0.272 9.209 0.267 9.219 0.278 8.652 0.286 9.449 0.320 9.514 0.415 9.643 0.328
WI 8.763 0.645 9.225 0.599 9.290 0.605 9.684 0.762 8.226 0.631 9.152 0.640 8.525 0.599
WV 8.657 0.602 9.106 0.575 9.647 0.566 8.763 0.514 7.056 0.490 9.088 0.538 10.168 0.510
WY 8.758 0.496 8.099 0.474 9.023 0.440 8.674 0.491 9.294 0.539 8.915 0.576 8.852 0.602
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Table D: The total number of  asthma discharge with standard error state by 
state over 2006 to 2012. 
  
Year
State Discharge
Standard
Error
Discharge
Standard
Error
Discharge
Standard
Error
Discharge
Standard
Error
Discharge
Standard
Error
Discharge
Standard
Error
Discharge
Standard
Error
AK 555.36 267.83 333.92 170.06 239.32 147.69 322.57 174.71 207.53 131.45 188.52 121.62 1,726.20 317.97
AL 5,265.23 1,415.54 4,809.04 1,324.97 4,579.17 1,330.89 4,649.24 1,350.49 4,553.53 1,336.96 3,175.43 983.59 7,794.25 784.48
AR 4,108.96 1,015.43 4,174.51 1,028.63 4,968.30 1,202.99 3,180.83 837.05 2,344.19 673.73 3,666.86 1,197.11 5,249.52 621.42
AZ 7,043.25 2,244.98 7,436.99 2,229.43 7,912.25 2,353.88 8,661.78 3,342.13 11,473.17 3,976.41 6,440.90 1,943.69 10,014.95 928.82
CA 37,313.00 3,596.78 30,953.87 2,886.38 31,835.73 3,045.90 39,482.00 3,907.74 35,601.00 5,011.15 31,433.51 3,177.84 42,841.29 2,211.15
CO 3,571.92 1,031.21 4,880.78 1,403.38 6,216.26 1,671.21 7,091.83 2,091.19 5,035.63 1,712.42 4,848.79 1,301.28 8,272.12 817.47
CT 10,622.90 4,262.71 5,269.71 1,837.55 8,218.97 3,974.70 5,571.59 2,657.19 4,729.78 2,208.92 4,405.91 1,853.26 6,144.49 668.32
DC 478.06 251.38 265.29 150.19 197.95 135.66 267.82 161.20 273.52 155.58 127.71 88.09 1,578.29 270.36
DE 732.44 333.71 460.58 221.31 351.25 199.88 451.77 230.37 460.90 222.14 226.82 130.78 2,081.11 343.29
FL 32,555.01 6,054.63 40,740.00 5,989.94 40,383.80 7,991.81 43,767.00 8,811.53 34,827.42 5,574.24 28,487.67 4,854.08 23,897.24 1,503.10
GA 12,718.26 2,178.44 17,693.06 6,148.55 11,444.54 2,181.26 12,102.73 2,523.49 14,690.70 3,775.79 9,352.40 1,939.02 14,070.76 1,145.80
HI 1,261.64 684.06 1,229.97 652.88 636.80 351.85 433.59 280.20 1,844.48 1,031.41 23.21 18.89 2,895.31 418.24
IA 2,746.00 725.19 2,956.76 761.21 2,640.12 879.51 2,436.84 816.65 2,831.46 870.49 1,767.15 503.12 5,427.54 629.89
ID 1,372.28 517.62 1,001.75 394.40 812.61 360.51 978.81 401.41 985.64 390.91 540.19 246.71 3,201.60 472.61
IL 24,701.37 4,945.83 20,603.18 3,394.44 19,325.04 3,569.67 22,025.37 4,050.63 19,893.80 3,791.40 17,971.87 3,318.73 17,359.03 1,282.58
IN 9,159.94 2,521.81 9,906.30 2,660.13 10,983.25 3,147.42 10,286.69 2,319.39 12,036.45 3,792.14 13,662.05 4,067.19 9,988.10 923.30
KS 2,270.58 646.02 3,957.63 1,581.71 3,845.00 1,752.60 2,322.64 692.24 2,957.96 1,051.96 2,567.52 849.99 5,158.12 621.91
KY 8,445.57 1,743.06 8,229.38 1,843.14 6,551.79 1,601.57 8,667.12 2,297.08 6,961.74 1,586.13 5,918.31 1,553.85 7,213.07 747.52
LA 4,792.63 1,316.95 4,440.07 1,244.62 7,340.12 1,730.48 6,497.40 1,365.84 8,912.43 2,957.05 6,699.83 1,630.58 7,512.79 775.70
MA 16,532.87 4,886.43 15,296.84 4,079.59 11,589.17 2,947.29 12,420.34 3,960.23 14,985.06 5,110.32 7,718.05 2,275.61 10,061.54 892.96
MD 10,647.34 2,943.86 10,461.91 2,680.28 13,292.16 3,631.16 9,008.74 2,986.87 9,663.62 2,827.27 10,391.73 2,896.45 9,148.22 860.26
ME 1,217.64 488.96 864.29 255.13 759.14 244.51 549.21 199.99 388.03 133.78 834.56 279.04 2,799.75 400.46
MI 9,273.21 2,693.64 10,020.05 3,582.71 10,246.94 2,697.00 8,253.83 2,189.21 12,147.10 4,282.29 7,523.50 2,164.37 13,939.70 1,112.71
MN 4,928.17 1,572.40 7,199.52 2,719.09 3,809.00 1,121.90 2,892.55 905.65 2,868.91 1,006.06 3,450.95 932.07 8,518.25 832.11
MO 10,335.67 3,314.56 8,433.59 2,499.58 7,641.97 1,871.77 9,517.39 2,358.86 8,426.06 2,122.48 8,229.64 2,547.28 9,327.60 875.26
MS 3,063.56 940.35 2,531.95 807.02 2,234.22 770.28 2,423.30 809.22 4,956.42 1,174.19 5,534.22 1,334.32 5,300.13 631.42
MT 827.82 366.26 529.66 247.35 410.95 225.73 782.64 342.13 772.77 341.71 333.24 161.85 2,238.20 357.93
NC 13,759.96 2,908.01 16,055.36 3,374.75 10,139.14 2,134.78 16,058.66 3,771.92 12,361.25 2,979.08 10,638.38 2,922.60 13,808.90 1,112.69
ND 523.23 263.72 300.31 161.29 219.79 143.19 293.34 168.23 310.96 164.56 383.73 191.94 1,683.90 299.91
NE 1,692.40 642.64 979.38 454.22 1,519.50 534.76 1,219.47 466.16 1,311.23 487.34 989.80 445.57 3,620.50 499.48
NH 1,308.26 402.96 2,220.27 771.57 725.80 491.35 1,438.47 712.09 778.24 336.31 411.92 208.17 2,781.83 403.06
NJ 22,938.75 4,631.32 22,813.01 4,722.17 13,867.81 3,411.41 16,820.08 4,176.07 21,631.45 5,475.92 18,191.58 4,407.34 12,754.63 1,053.41
NM 1,913.77 665.56 1,457.84 529.12 1,223.52 494.17 1,585.77 562.50 1,409.75 462.87 1,975.68 916.33 3,976.16 527.27
NV 3,201.80 1,105.29 3,078.61 1,335.12 3,190.27 1,262.74 4,036.50 1,896.64 4,210.20 1,518.93 2,307.36 915.30 4,976.27 600.97
NY 62,674.00 9,748.20 44,946.00 6,170.20 40,634.00 6,990.46 51,867.00 9,282.18 41,534.00 7,986.79 45,363.00 7,645.10 24,281.33 1,535.81
OH 17,903.38 3,386.55 20,448.24 4,090.92 17,941.50 3,676.88 22,866.95 4,331.64 18,567.86 4,103.53 21,689.19 5,708.51 15,832.59 1,203.71
OK 8,849.02 2,382.16 7,447.97 2,224.72 4,374.53 1,267.49 8,846.72 2,817.40 6,024.40 2,175.20 4,551.08 1,257.68 6,457.91 709.43
OR 3,062.35 927.64 3,067.82 908.77 3,233.28 902.98 3,751.23 1,175.18 1,926.31 675.41 2,001.28 719.69 6,564.30 695.73
PA 16,991.05 3,436.68 19,249.35 3,834.90 27,623.00 9,394.99 29,852.00 11,104.91 19,826.18 4,036.47 21,730.80 4,508.24 17,088.13 1,237.89
RI 1,205.88 680.68 349.86 270.41 810.23 556.69 1,935.86 1,194.05 1,683.78 1,011.70 2,105.38 1,149.72 2,324.43 359.58
SC 8,804.56 2,349.31 7,043.25 1,675.43 8,107.85 2,336.04 5,636.02 1,786.41 4,782.74 1,658.36 6,718.27 1,944.45 7,662.34 772.22
SD 438.97 190.86 166.64 60.92 86.46 45.50 327.98 193.74 181.36 74.68 1,028.01 544.16 1,919.30 335.23
TN 8,015.84 1,712.12 5,514.93 1,218.05 15,473.45 5,090.19 6,521.16 1,287.58 5,679.07 1,807.16 7,041.50 1,897.33 9,865.99 904.00
TX 31,818.00 4,924.79 28,162.41 4,040.01 26,572.54 4,125.23 32,929.00 5,553.35 27,656.92 4,686.84 26,819.00 5,030.44 31,653.39 1,892.38
UT 1,277.73 442.32 1,000.88 351.35 1,681.48 546.94 666.25 296.37 3,946.05 2,334.05 1,738.52 550.04 5,105.95 659.78
VA 11,966.87 2,907.53 10,416.71 2,721.69 10,185.34 2,907.14 11,547.19 2,919.93 12,947.05 3,295.01 15,154.45 3,444.50 11,949.41 1,010.46
VT 951.00 372.22 836.48 402.34 282.70 234.00 135.03 84.86 560.68 341.45 623.11 404.81 1,554.40 276.94
WA 5,159.09 1,121.15 5,063.46 1,284.43 4,028.28 1,039.67 7,010.54 3,076.97 3,588.72 1,199.26 3,716.83 1,131.60 10,405.30 932.06
WI 4,515.42 1,467.97 6,985.54 3,370.45 5,841.16 1,425.53 5,673.75 1,509.53 5,645.10 1,330.33 5,341.59 1,568.44 8,951.32 850.62
WV 3,171.12 1,151.47 4,843.99 1,521.30 3,840.30 1,432.38 4,038.64 1,314.96 4,485.17 1,258.61 2,698.85 1,109.35 3,637.49 475.25
WY 405.03 217.26 338.48 150.77 476.61 196.12 716.27 203.19 476.54 184.80 330.88 128.43 1,440.33 276.94
TOTAL 459,088.17 19,429.83 437,467.37 18,141.96 420,544.37 20,164.69 460,819.50 19,826.67 426,354.32 19,826.67 389,070.73 17,462.26 454,055.29 6,322.50
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Table E - 1: The total number of  asthma discharge among males with 
standard error state by state over 2006 to 2012. 
  
Year
State Discharge
Standard
Error
Discharge
Standard
Error
Discharge
Standard
Error
Discharge
Standard
Error
Discharge
Standard
Error
Discharge
Standard
Error
Discharge
Standard
Error
AK 195.03 84.76 139.75 69.09 81.02 43.04 108.39 51.27 124.76 78.27 69.44 42.63 595.22 234.06
AL 1,823.65 504.52 1,691.17 498.78 1,540.21 442.26 1,595.26 470.22 1,567.22 483.07 1,137.68 354.59 2,827.83 506.66
AR 1,408.68 317.30 1,523.94 353.14 1,666.45 378.61 1,004.07 253.81 728.29 232.12 1,382.33 631.36 1,882.60 415.52
AZ 2,700.51 1,057.82 3,040.72 1,075.16 3,123.90 1,113.72 4,313.88 2,023.23 5,662.78 2,424.67 2,098.57 633.29 3,807.22 592.55
CA 14,167.85 1,608.53 11,409.40 1,277.26 10,827.40 1,124.41 14,372.23 1,455.35 13,773.59 2,605.28 11,321.05 1,169.76 17,321.64 1,261.20
CO 1,392.46 451.11 1,971.55 599.42 2,531.60 675.26 3,163.14 1,049.79 2,055.83 830.81 2,055.83 613.56 3,091.44 528.34
CT 4,634.40 2,185.64 1,865.33 622.12 3,788.86 1,960.08 1,726.67 785.00 1,491.87 675.15 1,454.98 589.42 2,163.80 437.53
DC 138.03 66.40 92.59 50.47 51.97 32.04 71.70 38.71 80.31 43.59 49.76 31.07 440.46 186.92
DE 233.83 97.97 171.81 81.15 105.13 53.04 136.84 62.28 151.86 69.07 94.51 49.63 664.59 243.23
FL 11,154.06 2,106.88 16,075.38 2,728.79 14,212.75 2,844.59 15,954.95 3,047.83 13,374.59 2,640.65 9,024.31 1,808.04 9,111.95 885.72
GA 4,315.02 760.70 7,589.60 3,568.74 3,868.48 770.95 3,865.14 764.55 5,461.29 1,456.65 2,878.42 620.77 5,423.23 712.29
HI 536.60 291.81 422.29 233.47 276.58 156.90 169.58 89.85 876.45 608.68 14.10 10.39 969.74 289.84
IA 982.92 285.05 1,208.62 399.93 1,064.96 330.39 950.28 288.32 1,165.24 464.35 619.82 198.96 1,947.65 419.47
ID 483.26 173.68 395.98 158.41 278.44 112.71 338.25 129.17 361.02 141.09 235.11 102.12 1,156.67 332.14
IL 9,924.38 2,383.14 7,710.83 1,276.92 7,158.16 1,288.72 8,621.37 1,793.34 8,095.78 1,762.47 6,040.28 1,071.60 6,695.21 781.60
IN 3,027.92 700.73 3,592.33 957.80 4,574.13 1,721.56 3,748.16 906.34 5,166.50 2,200.63 5,274.81 2,229.03 3,761.60 588.43
KS 724.64 196.50 1,899.64 926.32 1,661.02 1,048.10 677.06 192.54 1,201.46 537.44 1,005.76 407.45 1,884.02 418.29
KY 2,585.69 530.70 2,767.19 673.78 2,130.67 495.37 2,529.05 621.82 2,116.36 467.10 1,676.64 463.99 2,626.45 486.72
LA 1,673.45 472.01 1,591.81 478.33 3,108.69 802.46 2,443.83 547.23 4,047.60 1,753.87 2,668.77 714.53 2,764.71 504.63
MA 7,008.29 2,441.78 5,387.85 1,350.64 4,344.30 1,148.71 4,629.07 1,490.41 5,580.22 1,799.77 3,071.11 964.21 3,621.65 561.00
MD 3,391.14 893.31 4,339.88 1,042.76 5,225.58 1,342.79 3,482.88 1,192.81 3,773.64 1,121.13 4,072.12 1,246.06 3,335.79 547.96
ME 388.58 146.15 293.51 81.59 268.57 94.36 153.27 47.80 159.00 62.34 364.16 114.96 893.06 274.50
MI 3,634.48 1,049.66 3,362.82 1,201.71 3,517.64 898.13 2,916.26 759.08 3,690.02 1,220.99 2,653.88 807.76 5,271.97 688.21
MN 2,123.07 699.49 3,327.48 1,548.48 1,304.87 357.95 1,016.83 258.50 1,064.27 361.08 1,220.35 335.15 3,168.56 535.76
MO 4,107.39 1,888.98 3,121.74 1,143.50 2,491.82 559.23 3,497.86 968.51 3,165.90 915.63 2,442.53 805.83 3,449.07 558.60
MS 1,062.83 328.12 931.40 313.83 750.44 249.68 830.06 274.16 1,868.55 494.53 1,938.14 474.79 1,910.49 422.88
MT 271.46 110.37 201.71 91.92 127.90 62.36 248.45 108.38 237.68 110.98 138.40 64.85 732.75 252.85
NC 5,202.21 1,138.30 6,131.09 1,430.56 3,355.46 662.00 6,113.00 1,791.22 4,218.46 964.23 4,546.15 1,540.39 5,223.40 689.21
ND 167.78 76.37 115.81 59.70 66.30 37.84 89.24 45.04 106.43 52.34 132.91 61.50 539.17 216.20
NE 826.28 345.35 415.87 235.22 600.55 196.81 404.44 128.16 386.20 131.30 395.06 252.65 1,284.10 345.05
NH 528.19 163.10 805.11 270.64 223.38 129.57 444.97 201.36 260.17 107.28 166.93 77.64 902.47 277.73
NJ 8,874.88 2,038.70 9,193.01 2,087.17 5,154.77 1,222.69 5,792.95 1,380.48 8,817.09 2,386.48 6,848.27 1,674.04 4,775.94 655.24
NM 658.98 222.02 548.49 203.84 406.77 152.51 586.67 218.59 548.32 187.95 882.11 465.50 1,409.92 360.45
NV 1,321.98 496.81 1,238.02 583.87 1,138.48 476.27 1,719.25 865.12 1,578.39 589.92 817.68 338.01 1,802.07 403.90
NY 25,006.00 4,160.45 18,621.78 2,861.02 16,516.16 2,886.15 21,318.00 4,028.20 16,655.18 3,388.52 17,298.11 3,046.94 9,304.01 906.77
OH 6,343.67 1,393.07 7,539.05 1,792.16 6,337.48 1,616.21 8,116.82 1,849.39 6,709.79 1,794.66 8,934.72 3,185.47 6,024.75 737.28
OK 3,816.25 1,282.83 3,164.66 1,208.03 1,354.16 349.26 3,896.03 1,470.09 2,456.44 1,169.11 1,685.87 559.59 2,377.61 468.19
OR 1,255.74 405.64 987.16 273.86 1,239.50 385.57 1,323.28 510.55 776.56 398.91 545.78 186.36 2,344.77 453.85
PA 6,047.85 1,336.82 6,366.38 1,418.20 11,377.93 5,384.50 12,669.44 6,228.37 5,790.48 1,122.69 6,472.45 1,280.31 6,428.38 749.89
RI 279.46 141.93 122.11 86.35 248.00 156.68 567.98 334.83 484.27 285.13 534.57 276.70 730.28 250.60
SC 2,957.91 729.36 2,747.86 668.04 2,638.43 682.89 1,910.01 560.21 1,951.41 823.86 2,404.56 744.77 2,764.65 498.31
SD 153.51 53.92 72.29 32.67 30.83 14.38 109.80 53.07 48.03 19.05 356.76 163.14 643.06 242.76
TN 2,237.16 467.34 1,650.00 378.93 5,973.31 2,571.61 2,043.32 420.00 2,111.29 837.11 2,556.43 855.17 3,643.75 573.69
TX 14,617.89 2,854.85 10,543.78 1,640.71 10,246.82 2,182.54 13,963.57 3,110.29 10,070.93 2,394.29 10,711.84 2,666.94 12,870.34 1,109.84
UT 375.52 117.82 329.26 103.43 586.94 161.65 245.57 141.38 2,031.56 1,384.22 621.88 216.73 2,017.49 453.05
VA 4,917.59 1,381.39 3,973.68 1,259.53 3,641.39 1,112.96 4,071.17 1,301.59 5,113.85 1,473.23 6,156.14 1,590.60 4,463.37 631.02
VT 355.01 170.80 365.39 187.13 86.25 58.58 37.49 23.19 235.11 142.77 215.19 132.38 466.92 197.68
WA 2,064.04 478.74 1,852.97 477.82 1,452.64 363.23 3,214.36 1,848.29 1,162.84 368.13 1,202.87 354.21 3,902.06 590.03
WI 1,577.20 494.48 3,252.19 1,935.92 2,080.39 470.19 2,170.78 547.34 2,078.83 466.30 1,839.53 520.94 3,313.76 544.36
WV 1,181.31 511.68 1,721.60 492.80 1,315.06 459.35 1,393.25 493.86 1,470.35 464.06 839.74 352.01 1,208.52 321.18
WY 132.27 63.21 173.14 89.39 165.84 83.54 295.57 93.02 176.31 68.03 168.02 70.67 465.83 203.78
TOTAL 174,988.31 8,568.15 168,057.03 8,222.89 156,318.41 9,120.86 175,061.46 10,539.10 162,280.41 8,886.21 141,336.40 7,516.35 170,426.01 3,929.17
Asthma Discharge among Males over Years 2006 to 2012
2006 2007 2008 2009 2010 2011 2012
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Table E - 2: The total number of  asthma discharge among females with 
standard error state by state over 2006 to 2012. 
  
Year
State Discharge
Standard
Error
Discharge
Standard
Error
Discharge
Standard
Error
Discharge
Standard
Error
Discharge
Standard
Error
Discharge
Standard
Error
Discharge
Standard
Error
AK 339.49 182.05 186.06 108.96 143.99 99.87 204.17 102.46 125.36 66.91 119.08 84.43 916.12 184.34
AL 3,443.14 977.79 3,129.29 903.19 3,042.08 943.37 3,064.96 1,220.71 3,018.81 924.36 2,090.50 669.48 4,657.09 429.12
AR 2,700.29 734.98 2,650.57 729.80 3,301.85 867.22 2,176.75 608.43 1,610.77 453.84 2,284.53 657.38 3,063.31 344.11
AZ 4,342.74 1,353.60 4,396.27 1,317.71 4,788.35 1,426.10 4,347.90 1,407.95 5,810.39 1,723.49 4,342.32 1,352.02 5,877.21 493.46
CA 20,011.25 1,934.23 17,189.48 1,584.59 18,878.54 1,909.10 22,410.15 2,449.73 20,001.08 2,510.78 18,459.85 1,995.53 25,327.41 1,101.19
CO 2,179.45 644.62 2,909.22 848.00 3,684.66 1,075.83 3,928.68 1,151.28 2,979.80 1,008.03 2,792.96 751.35 4,808.14 439.85
CT 5,988.51 2,424.17 3,404.38 1,271.16 4,430.11 2,221.04 3,844.92 1,886.58 3,237.92 1,578.24 2,950.93 1,278.10 3,634.05 371.85
DC 344.74 191.09 180.57 113.36 147.24 106.16 204.92 108.36 197.57 114.41 83.28 56.83 877.75 164.70
DE 497.07 244.22 293.33 157.38 243.10 149.71 319.84 158.20 314.27 158.35 145.43 83.89 1,175.57 202.30
FL 21,400.49 4,168.29 24,665.85 3,609.49 26,170.21 5,455.16 27,812.24 6,207.91 21,452.27 3,281.75 19,462.50 3,310.11 14,700.56 797.32
GA 8,403.24 1,504.46 10,103.45 2,718.02 7,576.06 1,523.73 8,237.45 1,812.70 9,229.57 2,373.71 6,473.98 1,404.61 8,403.19 599.82
HI 725.04 399.33 807.68 422.58 360.22 198.52 261.80 197.06 968.03 492.97 59.70 36.83 1,609.65 239.67
IA 1,763.08 522.55 1,748.14 443.26 1,575.17 574.71 1,486.56 548.60 1,666.22 471.96 1,147.33 339.24 3,147.02 348.20
ID 864.62 356.63 593.26 258.52 512.19 251.62 627.74 282.76 620.18 261.80 328.62 153.76 1,809.50 265.09
IL 14,776.78 2,798.78 12,892.19 2,210.61 12,166.99 2,369.19 13,403.44 2,494.10 11,797.39 2,247.33 11,931.09 2,309.89 10,420.13 670.50
IN 6,132.02 1,908.23 6,313.97 1,753.85 6,409.12 1,632.43 6,538.53 1,538.26 6,869.94 1,806.41 8,387.25 2,094.21 5,917.66 493.22
KS 1,545.94 473.03 2,057.98 730.70 2,183.98 815.95 1,645.58 526.19 1,756.50 607.08 1,561.76 509.09 2,975.48 341.85
KY 5,859.88 1,320.62 5,462.19 1,282.63 4,421.11 1,196.64 6,138.07 1,753.87 4,845.38 1,173.41 4,241.67 1,144.58 4,246.74 408.52
LA 3,109.38 905.33 2,847.87 838.97 4,231.43 1,040.79 4,053.57 880.26 4,864.82 1,361.39 4,023.62 1,055.23 4,443.64 421.51
MA 9,524.58 2,636.38 9,908.98 2,798.23 7,244.87 1,941.83 7,791.27 2,547.76 9,405.00 3,422.00 4,646.94 1,414.37 6,095.28 489.91
MD 7,256.20 2,087.37 6,122.03 1,712.86 8,066.12 2,364.92 5,525.86 1,919.17 5,889.98 1,825.41 6,319.61 1,804.83 5,502.31 468.50
ME 822.69 353.56 570.78 194.01 490.58 169.43 395.94 157.51 229.03 84.87 470.39 178.69 1,587.78 233.29
MI 5,638.74 1,741.11 6,657.22 2,422.36 6,729.30 1,879.22 5,337.57 1,517.51 8,457.02 3,092.02 4,869.62 1,449.26 8,375.07 591.26
MN 2,805.11 904.70 3,872.05 1,356.01 2,504.13 790.13 1,875.72 665.90 1,804.64 684.05 2,230.61 654.06 4,998.42 448.68
MO 6,228.28 1,593.75 5,311.85 1,454.90 5,150.16 1,345.29 6,019.54 1,551.02 5,260.16 1,351.89 5,787.11 1,774.39 5,554.33 472.95
MS 2,001.04 656.61 1,610.04 547.68 1,480.39 551.90 1,604.77 670.00 3,087.87 781.80 3,596.08 937.78 3,121.02 349.13
MT 541.64 259.85 324.65 169.86 270.91 162.20 534.18 241.72 535.09 237.27 194.84 102.10 1,231.94 208.13
NC 8,557.75 1,941.32 9,924.50 2,179.62 6,783.68 1,540.37 9,945.28 2,249.05 8,142.79 2,100.56 6,092.23 1,530.58 8,324.80 590.68
ND 344.03 188.03 182.98 111.51 145.48 103.29 200.87 103.95 200.49 111.40 250.82 145.08 902.83 176.78
NE 866.12 335.27 563.51 268.97 918.95 353.74 815.03 347.91 925.03 371.05 594.74 215.80 2,064.44 280.48
NH 780.07 264.04 1,415.16 529.83 502.42 370.40 993.50 521.17 517.72 234.80 257.46 132.21 1,567.46 233.73
NJ 14,063.76 2,851.73 13,620.55 2,879.65 8,713.53 2,297.72 11,027.01 2,873.29 12,815.14 3,325.49 11,343.14 2,853.90 7,690.65 563.51
NM 1,232.95 463.37 899.16 355.55 795.38 350.64 999.10 369.08 861.42 295.69 1,093.57 480.29 2,281.86 295.39
NV 1,879.82 670.60 1,831.52 801.59 2,051.79 805.87 2,317.25 1,125.92 2,631.81 985.37 1,489.68 601.68 2,835.30 331.40
NY 37,668.59 6,091.70 26,323.61 3,604.97 24,116.90 4,383.07 30,548.18 5,634.17 24,878.50 4,912.55 28,060.17 4,898.05 14,945.50 808.51
OH 11,559.61 2,204.13 12,909.95 2,563.22 11,604.05 2,268.79 14,745.06 2,736.41 11,858.00 2,504.69 12,754.18 2,794.45 9,558.99 636.22
OK 5,032.76 1,312.59 4,283.31 1,186.25 3,020.36 940.71 4,950.68 1,539.48 3,567.96 1,224.97 2,865.22 786.77 3,764.36 386.48
OR 1,806.62 569.57 2,080.66 653.81 1,993.77 558.66 2,427.95 764.35 1,149.75 344.03 1,455.50 546.61 3,842.47 384.07
PA 10,925.66 2,268.16 12,795.84 2,572.01 16,245.16 4,257.60 17,183.31 5,190.45 14,035.76 3,012.74 15,252.51 3,264.19 10,421.95 660.98
RI 926.42 545.12 227.74 195.78 562.23 402.93 1,367.89 862.48 1,199.51 729.31 1,570.81 875.96 1,316.84 211.56
SC 5,846.65 1,717.55 4,295.39 1,106.17 5,469.41 1,760.63 3,726.01 1,295.49 2,831.33 961.57 4,313.71 1,312.12 4,569.56 423.68
SD 285.46 143.99 94.35 48.94 55.63 32.65 218.18 148.25 133.33 61.62 671.25 406.43 1,054.98 195.44
TN 5,778.68 1,296.47 3,864.93 884.61 9,500.14 2,907.72 4,477.83 938.15 3,567.78 1,030.60 4,485.07 1,179.33 5,908.68 488.49
TX 17,195.77 2,270.47 17,618.90 2,701.67 16,309.74 2,223.67 18,960.77 2,741.32 17,563.53 2,590.17 16,108.07 2,733.01 18,428.26 934.20
UT 902.21 337.61 671.62 264.71 1,094.53 408.23 420.68 172.83 1,914.49 1,011.82 1,116.64 361.71 2,903.67 351.83
VA 7,044.48 1,652.09 6,443.02 1,616.21 6,543.95 1,948.34 7,476.02 1,812.69 7,833.20 2,051.08 8,998.31 2,096.17 7,156.74 541.73
VT 596.00 236.03 471.09 233.90 206.29 178.09 97.54 66.53 325.57 222.15 407.92 308.17 843.76 165.76
WA 3,095.05 708.09 3,210.49 901.93 2,575.64 736.63 3,796.19 1,355.63 2,425.88 873.06 2,513.95 816.12 6,125.59 499.20
WI 2,938.22 993.98 3,733.35 1,495.41 3,760.78 990.32 3,502.97 1,006.25 3,566.27 914.89 3,502.06 1,063.69 5,271.05 459.59
WV 1,989.81 729.85 3,122.38 1,086.20 2,525.24 1,062.26 2,645.39 946.79 3,014.81 881.61 1,854.16 811.84 2,080.60 272.11
WY 262.80 154.19 165.34 69.90 310.77 146.92 420.71 137.96 300.23 124.33 162.86 62.22 766.26 164.14
TOTAL 280,824.72 11,969.24 266,958.74 10,915.50 262,008.70 12,199.46 283,055.54 13,702.76 262,295.35 12,043.63 246,215.66 10,925.58 269,102.97 3,353.38
Asthma Discharge among Females over Years 2006 to 2012
2006 2007 2008 2009 2010 2011 2012
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Asthma Distribution by Gender Decennially over Years 
Age Male Female 
0-9 422477.8 238744.8 
10-19 95813 77057.08 
20-29 46942.8 91756.1 
30-39 62439.32 148780.7 
40-49 104887.6 285747.6 
50-59 117074.6 327800.7 
60-69 90970.2 244459.8 
70-79 76188.9 189609.8 
80-89 48300.39 133598.2 
90-99 7412.5 28218 
100-109 121.23246 595.5988 
110-119 0 4.69179 
Table F: The total number of  asthma distribution by gender decennially 
over 2006 to 2012. 
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Asthma Distribution by Gender  
between Children and Adult over Years 
Age Male Female 
Child (< 18) 523034 310345.3 
Adult (≧ 18) 564348 1449229 
Table G: The total number of  asthma distribution between children and 
adult over 2006 to 2012. 
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Table H: Average length of  stay by gender over year 2006 to 2012. 
  
Gender 2006 2007 2008 2009 2010 2011 2012
Male 2.67477 2.60799 2.89158 2.77607 2.82539 2.81738 2.75207
Female 3.44632 3.41526 3.74608 3.62132 3.61547 3.61691 3.54576
Male(Percent) 0.43698 0.43299 0.43563 0.43394 0.43867 0.43787 0.43699
Female(Percent) 0.56302 0.56701 0.56437 0.56606 0.56133 0.56213 0.56301
Average Length of Stay (Days) by Gender over Years
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Table I: Average charges by gender over year 2006 to 2012. 
  
Gender 2006 2007 2008 2009 2010 2011 2012
Male 11336.1 11854 14152.9 15607.2 16142.4 17172.2 18799.2
Female 14292.3 15048.6 17356.3 18929 19861.7 21238.2 22574.2
Male(Percent) 0.44233 0.44063 0.44917 0.45191 0.44835 0.44707 0.45438
Female(Percent) 0.55767 0.55937 0.55083 0.54809 0.55165 0.55293 0.54562
Average Charges by Gender over Years
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Top 5 Asthma Diagnoses by Gender over Years 
ICD-9 code Male         Female 
493.92 466199.2744 718121.2261 
493.22 286415.6696 668093.7841 
493.91 160139.6864 147111.7749 
493.90  66241.53393 87912.93733 
493.02 46288.81302 48528.38665 
Table J: Top 5 asthma diagnoses by gender over year 2006 to 2012. 
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Table K: Average length of  stay of  top 5 prevalent subtypes over year 2006 
to 2012. 
  
Year
ICD-9 male female male female male female male female male female male female male female
49392
Average
2.3492 3.08807 2.29071 3.06454 2.26746 3.0895 2.21731 2.92665 2.2451 2.96133 2.25431 3.04288 2.18397 2.93877
49322
Average
4.45796 4.96006 4.34233 4.81928 4.38436 4.85804 4.27578 4.75872 4.26833 4.67998 4.10931 4.57879 4.01866 4.40604
49391
Average
2.69567 3.30809 2.40989 3.18504 2.54109 3.18946 2.46405 3.03777 2.60338 3.06313 2.63396 3.19281 2.49425 3.02055
49390
Average
2.304 2.90046 2.26105 2.92262 2.35381 3.01648 2.31917 2.95158 2.26956 2.88592 2.26878 3.0044 2.19986 2.80879
49302
Average
2.20673 2.73478 2.20327 2.792 2.2315 2.93763 2.09136 2.80119 2.07371 2.73484 2.14531 2.9534 2.06509 2.80921
49392
LOS
169640 333870 154769 307313 146616 317809 164998 330531 155736 308855 132828 300448 128985 267090
49322
LOS
164399 431230 163728 414639 191516 487577 191900 505404 185418 475856 169448 453328 155100 387115
49391
LOS
58273 72307 58743 72959 55498 66246 65626 69399 56876 60424 51299 58494 60735 62480
49390
LOS
27072 46704 25323 42661 23353 40098 22986 38820 19901 32920 17607 31851 15245 24605
49302
LOS
23320 24781 15416 19199 11717 16884 13706 20502 10808 17718 10615 18327 13960 19215
2006 2007 2008 2009 2010 2011 2012
Average Length of Stay of Top 5 Prevalent Subtypes
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Table L: Average Charges of  top 5 prevalent subtypes over year 2006 to 
2012. 
  
Year
ICD-9 male female male female male female male female male female male female male female
49392
Average
9311.83 12460.9 9907.9 13205 10610 14120 11481.8 15091.7 12021 16199.5 12723.7 17167.9 13866.7 18557
49322
Average
19561.7 20796.6 20451 21570 22442 22669 24607.7 24913.7 24696 25502 26316.9 27284.4 26809.7 27545
49391
Average
12232.1 14822.7 11613 14921 12293 15337 16184.5 18353.9 16311 18300.5 16932.6 20643.5 20372.9 21702
49390
Average
8921.88 10943 9525.6 11918 10913 13637 11400 14117.2 11855 15081.7 12118.7 15852.1 13471.4 16829
49302
Average
9442.77 10846.1 9113 11416 9921.7 13330 10288.8 13713.4 10766 14137.1 11748.6 15919.7 13629.2 16416
49392
Charges
6.7E+08 1.3E+09 7E+08 1E+09 7E+08 1E+09 8.5E+08 1.7E+09 8E+08 1.7E+09 7.5E+08 1.7E+09 8.2E+08 2E+09
49322
Charges
7.2E+08 1.8E+09 8E+08 2E+09 1E+09 2E+09 1.1E+09 2.6E+09 1E+09 2.6E+09 1.1E+09 2.7E+09 1E+09 2E+09
49391
Charges
2.6E+08 3.2E+08 3E+08 3E+08 3E+08 3E+08 4.3E+08 4.2E+08 4E+08 3.6E+08 3.3E+08 3.8E+08 5E+08 4E+08
49390
Charges
1E+08 1.8E+08 1E+08 2E+08 1E+08 2E+08 1.1E+08 1.9E+08 1E+08 1.7E+08 9.4E+07 1.7E+08 9.3E+07 1E+08
49302
Charges
1E+08 9.8E+07 6E+07 8E+07 5E+07 8E+07 6.7E+07 1E+08 6E+07 9.2E+07 5.8E+07 9.9E+07 9.2E+07 1E+08
2006 2007 2008 2009 2010 2011 2012
Average Charges of Top 5 Prevalent Subtypes
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Table M: Asthma Distribution by Admission Type over year 2006 to 2012. 
  
Admission
Type
Gender 2006 2007 2008 2009 2010 2011 2012
Elective Male 148480 141889 141760 160719 150495 127275 137400
Female 235159 221389 235832 257907 240329 223003 212900
Non-Elective Male 12903 13514 10822 10817 9146 9646 7820
Female 20505 21823 18934 18582 16770 17846 13250
Asthm Distribution by Admission Type over Years
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Table N: Age Distribution of  Asthma Discharges by Race over year 2006 to 
2012. 
  
Year
Age Race Male Female Male Female Male Female Male Female Male Female Male Female Male Female
Age < 18 white 23202 14371.2 21479.9 12816.4 22359.6 13358.2 26094.9 15603.4 24959.9 15035.6 18839.3 11564.3 22845 13665
black 18485.7 11486.6 17724.9 10208.5 20658.5 12332.3 20000.3 11886.2 24580.2 14302 18220.9 10833.3 23490 14265
hispanic 16971.6 10152.8 12835.3 7603.73 10499.7 5931.78 18464.5 11024.6 15490.2 9015.12 10873.1 6497.7 14805 8935
asian or pacific island 927.49 580.313 1018.35 606.047 1075.02 664.713 1697.63 838.652 2328.52 1218.93 1199.78 593.981 1910 1030
native america 595.742 328.956 681.294 372.423 408.806 224.383 758.112 418.895 543.646 315.23 404.895 230.376 525 330
other 2835.19 1536.22 2530.62 1710.19 3519 1834.34 5603.34 3539.97 3240.76 1870.82 2933.33 1934.25 3615 2030
Age ≧ 18 white 31082.9 86187.1 30240.7 83314.6 38595.8 103806 39713.8 108941 38076.3 104652 38638.4 104712 37320 96510
black 16424.6 38971.2 16965.4 37022.3 16658.6 40683 20331.2 47893.6 23219.5 54747.2 20581.4 52275.6 20105 50250.1
hispanic 8710.19 23739.9 7422.3 18569.8 8598.51 21313.6 10048.3 26077.9 9082.35 24059.9 8119.85 22204.1 8745 20935
asian or pacific island 1789.21 2693.59 1506 2541.82 1892.33 2867.57 2015.59 3497.7 1915.33 3344.3 1644.24 2755.04 1915 3065.01
native america 441.411 1131.3 401.917 1158.13 245.814 1087.08 386.163 1357.01 449.782 1359.3 477.123 1488.94 460.003 1185
other 1672.48 3515.64 1949.83 3784.43 2297.55 5418.87 4619.1 9937.05 2193.85 4271.69 2707.34 5604.38 2740 5285
2012
Age Distribution of Asthm Discharges by Race over Years
2006 2007 2008 2009 2010 2011
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Table O: Primary expect payer of  asthma by Race over year 2006 to 2012. 
  
white black hispanic
asian or
pacific
island
native
america
other
Medicare 448630.4 150245.4 75268.47 16343.3 4651.524 19322.12
Medcaid 224355.8 281835.6 177930.5 13106.96 6556.673 37034.49
Private including HMO 402400.1 156609.6 79609.7 15500.16 4095.191 23701.69
Self-pay 77610.33 67122.57 29468.2 2759.102 1222.415 10952.79
no charge 8280.11 6077.116 3981.548 159.8227 99.14262 679.7697
other 34008.6 21088.69 10161.21 1181.893 1061.559 2841.311
White(Percent) 0.627928278 0.302848 0.590102 0.410343 0.429522 0.483466
Black(Percent) 0.210291891 0.380437 0.229661 0.354892 0.315244 0.299797
Hispanic(Percent) 0.105349974 0.24018 0.116744 0.155805 0.206539 0.144452
Asian or Pacific Island(Percent) 0.022875 0.017693 0.02273 0.014588 0.008291 0.016802
Native America(Percent) 0.006510534 0.008851 0.006005 0.006463 0.005143 0.015091
Other(Percent) 0.027044323 0.049991 0.034757 0.05791 0.035262 0.040392
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Code: 
/*Domain analysis of asthma discharge by gender wise*/ 
data nis2006.asthma_gender; 
 set nis2006.asthma 
      nis2006.NIS_2006_Hospital(in=inhosp keep=hospid nis_stratum); 
     insubset = 1; 
    IF inhosp THEN DO; 
         insubset = 2;     * Assign a value outside the subset ; 
        discwt = 1;     * Assign a valid weight ; 
        died = 0;     * Set analysis variables to zero ; 
        dischgs = 0; 
        los = 0; 
        totchg = 0; 
    END; RUN;  
 
PROC SURVEYMEANS DATA=nis2006.asthma_gender SUM STD MEAN STDERR; 
    WEIGHT discwt ; 
    CLASS died ; 
    CLUSTER hospid ; 
    STRATA nis_stratum ; 
    VAR dischgs los died totchg ; 
    DOMAIN insubset * female; RUN; 
